DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	IGKV1D-8; IGLV3-21; IGKV3-11; IGLV5-45; IGLV3-19; IGLV2-14; IGKV1D-39; IGKV1-9; IGKV2D-29; IGLV4-69; IGLV2-23; IGKV1D-16; IGKV3-20; IGKV2-24; IGLV2-8; IGKV4-1; IGKV1-16; IGLV6-57; IGLV2-11; IGKV3D-11; IGKV1-27; IGKV1-6; IGKV1-12; IGKV1-17; IGLV1-40; IGLV3-1; IGLV1-44; IGKV3D-20; IGKV1-5; IGLV3-25; IGLV8-61; IGLV1-36; IGLV7-43; IGLV3-9; IGLV3-27; IGKV2-30; IGLV1-47; IGKV3-15; IGLV3-10;	GO:0002377~immunoglobulin production	39	107	36.4485981308411	0	0	0	0	0	0	0
up	COLEC12; IGHV3-11; IGHV4-39; IGHV3-74; IGHV1-69; IGLL5; IGHG2; IGHV3-30; IGHV1-2; IGHV4-4; IGHV3-43; TRDC; IGHV1-46; IGHV3-66; TRBC2; IGHA2; IGHA1; IGHV1-3; IGHV1-18; IGHG4; IGHV3-15; IGHV3-49; IGHV1-69-2; IGHV3-20; IGHV3-21; IGLC7; IGLC3; IGHV3-23; IGHV2-70; IGHV3-53; IGHG3; IGHV3-7; IGHV4-61; IGHV2-5; IGHD; TRBC1; IGHV5-51; IGHV3-73; IGLC2; IGKC; IGHV6-1; IGHV4-31; IGHV3-48; IGHV1-24; IGHV4-59; IGHV4-34; IGHV3-33;	GO:0006910~phagocytosis, recognition	47	99	47.4747474747475	0	0	0	0	0	0	0
up	IGKV3D-20; IGKV1-12; IGLC7; FCN1; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; C1QA; C1QB; C1QC; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; IGLC2; IGLC3; IGHV1-2; IGLV3-21;	GO:0006956~complement activation	52	92	56.5217391304348	0	0	0	0	0	0	0
up	IGKV3D-20; IGKV1-12; IGLC7; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; CD3G; IGLC2; IGLC3; FCGR2A; IGHV1-2; FCGR2B; NCKAP1L; IGLV3-21;	GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis	52	135	38.5185185185185	0	0	0	0	0	0	0
up	TRGV2; TRGV8; TRGV4; LILRA5; CD300LB; TYROBP; LY86; JCHAIN; C1QA; C1QB; C1QC; TRGV3; S100B; CFI; KLRC2; LILRA4; NAIP; SLAMF1; COLEC12; TRIL; CLEC10A; ZNF683; LILRA2; CLEC4C; RNASE6; PLD4; SIGLEC10; CD180; RARRES2; CD209; TLR8; TLR7; CD84; TRDC; IGHV3-15; IGHA1; IGHV3-66; IGHV4-61; IGHV3-48; IGHV2-70; IGHV1-69-2; IGHV4-59; IGHV3-23; IGHV4-39; TRBC1; IGHV3-53; IGHV1-3; TRBC2; IGHV4-4; IGHV3-30; IGLC3; IGHV3-49; IGLC7; IGHV1-2; IGHV3-21; IGHV6-1; IGHV5-51; IGHV3-7; IGHV3-33; IGHV1-18; IGHV1-46; IGHG4; IGHA2; IGLL5; IGLC2; IGHV3-74; IGHV1-24; IGHV3-73; IGHV4-31; IGHG3; IGHV3-11; IGHV1-69; IGHV4-34; IGKC; IGHV2-5; IGHD; IGHG2; IGHV3-43; IGHV3-20;	GO:0045087~innate immune response	79	505	15.6435643564356	0	0	0	0	0	0	0
up	IGKV3D-20; IGKV1-12; IGLC7; CD300LB; NCR3; TYROBP; LILRA1; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; TRBC1; IGLV7-43; CD3D; IGKV1-16; IGKV1D-39; IGKV3-11; CD1A; IGKV2-30; IGKV4-1; IGHV4-34; CD3G; IGLC2; IGLC3; CD8B; CD19; VCAM1; IGHV1-2; KLRC1; CD1B; CD1C; CD40LG; FCGR2B; ICAM3; IGLV3-21; COLEC12; LILRB2; LILRB1; CD300LF; KIR2DL4; CD300A; SIGLEC7; BTNL3;	GO:0050776~regulation of immune response	70	216	32.4074074074074	0	0	0	0	0	0	0
up	IGHV3-53; IGHG3; IGHV3-49; IGHV1-69-2; IGHG4; IGLC7; IGLC3; IGHV3-15; IGHV4-39; IGHV2-70; IGHV3-21; IGHD; IGHV4-59; IGHV1-69; IGHV4-4; IGHV3-73; IGHV3-23; IGHV1-2; TRBC1; IGHV1-18; IGLL5; IGHV1-24; IGHA1; IGHV3-74; IGHV3-48; IGHV3-11; TRBC2; IGHG2; IGHV3-33; IGLC2; IGHV3-20; IGHV1-46; IGHV4-31; IGHV5-51; IGHV4-61; IGHV1-3; IGHV6-1; IGHV4-34; IGHV3-66; IGHV3-7; IGHA2; TRDC; IGKC; IGHV3-30; IGHV3-43; IGHV2-5;	GO:0050871~positive regulation of B cell activation	46	98	46.9387755102041	0	0	0	0	0	0	0
up	IGKV3D-20; IGKV1-12; IGLC7; JCHAIN; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHA1; IGHA2; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; CEACAM5; CD48; IGLC2; IGLC3; PSG1; SELE; IGHV1-2; CEACAM3; IGLV3-21; ANGPT1; SIRPG; CD84;	GO:0050900~leukocyte migration	56	193	29.0155440414508	0	0	0	0	0	0	0
down	EBAG9; PDCD5; KIF1B; PPP1R15A; JTB; LTA; IL1A; ITGB2; S100A8; PRKCB; CD14; CGB7; PIM1; PRF1; NCF1; DPEP1; RPS3; PAX3; MT3; PRDX5; NUDT2; GZMM; DAD1; POLR2G; RACK1; CSNK2A1; PPP2R2B; PRKCE; FOXO1; STK4; STK3; PMAIP1; SEMA3A; SIX1; EMC4; GDF6; ADAMTSL4; PDCD6IP; SH3KBP1; CYFIP2; ITCH; NOX5; GSDMA; PLEKHF1; BCL7B; MIEN1; BEX2; CSRNP2; HIPK3; PLK3; TRIM39; S100A14; UXT; MTFP1; STK17A; SAP30BP; FBXO10; NCKAP1; EPB41L3; CASP5; FIS1;	GO:0006915~apoptotic process	61	552	11.0507246376812	0	0	0	0	0	0	0
down	KIF1B; SNAPIN; AP3M2; BLOC1S1; KIF1A; BLOC1S3; BLOC1S2;	GO:0008089~anterograde axonal transport	7	31	22.5806451612903	0.00012511365717982	0.00738357314162702	0.486441899115142	0.494699400489011	0.357060404364841	0.486441899115142	0.0654171667772731
down	RGS10; RGS11; GRK4; RGS2; TUB; DYNLT1; HOMER2; PHF24;	GO:0008277~regulation of G protein-coupled receptor signaling pathway	8	43	18.6046511627907	0.00013583252270676	0.00780044070679577	0.527981015761212	0.537081794782565	0.371094452034893	0.527981015761212	0.0691105405018368
down	EREG; IL1A; ITGB2; HCK; PIM1; CCL5; FER; IL1RN; TNFRSF1B; EDN2; IL32; PTPN6; IL12A; OPRD1; UBA52; BCL2L1; FOXO1; IL18; IL34; IFNL1; GREM2; IFNGR2;	GO:0019221~cytokine-mediated signaling pathway	22	278	7.9136690647482	0.00013656470657319	0.00780044070679577	0.530690449743434	0.539976849790411	0.372023819201799	0.530690449743434	0.0691105405018368
down	RBX1; NEDD8; UBE2F; DCUN1D5; DCUN1D3;	GO:0045116~protein neddylation	5	13	38.4615384615385	0.00015349050303148	0.00818408982113229	0.595696642265188	0.606901448986487	0.392475216251504	0.595696642265188	0.072509604561352
down	RPLP1; EEF1B2; EIF5AL1; ABTB1; EIF5A2; EEF1A2;	GO:0006414~translational elongation	6	22	27.2727272727273	0.00015937655949094	0.00818408982113229	0.618221674265366	0.630174916227186	0.399143447213027	0.618062297705875	0.072509604561352
down	UROS; ALAS2; FXN; SLC25A39; TMEM14C; SRRD;	GO:0006783~heme biosynthetic process	6	22	27.2727272727273	0.00015937655949094	0.00818408982113229	0.618221674265366	0.630174916227186	0.399143447213027	0.618062297705875	0.072509604561352
down	RNMT; POLR2I; POLR2J; POLR2K; POLR2F; POLR2G; GTF2H5;	GO:0006370~7-methylguanosine mRNA capping	7	33	21.2121212121212	0.0001753634826378	0.00857610188211125	0.679708858704123	0.693387210349871	0.41736508867797	0.679533495221485	0.0759827628655862
down	HOXD9; MSX1; HOXA11; WNT3; EN1; OSR2; ALX4;	GO:0035115~embryonic forelimb morphogenesis	7	33	21.2121212121212	0.0001753634826378	0.00857610188211125	0.679708858704123	0.693387210349871	0.41736508867797	0.679533495221485	0.0759827628655862
down	PRF1; EIF2S2; SLC6A2; AZGP1; SLC6A1; ADD2; MPV17; PEX19; PSMC4; SLCO1A2; SLC6A11; PSMD8; AQP4; PSMC6; UBA52; PDZD11; MFSD14B; NIPA1; SLC16A9; PSMB7; SLC46A2; ATP6V0E1;	GO:0055085~transmembrane transport	22	285	7.71929824561404	0.00018938579336469	0.00913209057273169	0.733491177701458	0.748831426963999	0.431988994664866	0.733491177701458	0.0809087254318053
down	NCAN; TOR1A; PSTPIP1; DSCAM; LRRN2; ITGB2; HCK; SELL; IL32; FPR2; AZGP1; ABL2; CX3CR1; SLURP1; RND3; PRKCE; TYRO3; SELPLG; OPCML; SPECC1L; AMTN; LY9; CFDP1; NINJ2; PCDHB8; PCDHAC2; PCDHA11; ICAM2; SIGLEC9; FER;	GO:0007155~cell adhesion	30	454	6.6079295154185	0.00019889057992306	0.00931253729945916	0.76990543488217	0.786413353015784	0.441579082333302	0.76990543488217	0.0825074518736405
down	DUSP11; POLR2I; POLR2J; POLR2K; POLR2F; POLR2G; WTAP; LSM1;	GO:0016070~RNA metabolic process	8	46	17.3913043478261	0.00020490408322027	0.00931253729945916	0.792568993896003	0.810190745052947	0.447708885146149	0.792568993896003	0.0825074518736405
down	CLTA; PIM1; MAPK4; RGS2; RACK1; CSNK2A1; PRKCE; PIN1; TP53BP2; WTAP; USP39; SPECC1L; PYHIN1; RINT1; PMF1; BANP; PTP4A1; ANAPC16; BEX2; RBM38;	GO:0007049~cell cycle	20	248	8.06451612903226	0.00021379348497629	0.00960612999541234	0.826739406403348	0.845339439596286	0.456247399950654	0.826739406403348	0.0851086318155686
down	VNN2; PDZD11; PANK2; VNN3;	GO:0015939~pantothenate metabolic process	4	7	57.1428571428571	0.00023005701078271	0.0101071713403872	0.889170346675189	0.90964542063485	0.47083102134973	0.889170346675189	0.0895477705086958
down	EREG; TGFA; AREG; PTPN2; CDC42; EPGN; SH3KBP1;	GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway	7	35	20	0.00024078078195588	0.0104620572731161	0.930376941477539	0.952047211853569	0.479394536874167	0.930376941477539	0.0926919978093439
down	ITGB1BP1; PDCD5; EREG; IL1A; FTH1; SOD2; AR; FOSL1; TIMP2; PTPN2; WT1; AZGP1; MSX1; DUSP1; PTPN6; ADM; SSTR5; CDKN2B; SLURP1; CSNK2B; PTH1R; STK4; STK3; CAMK2N1; IFNL1; KAT2B; RGCC;	GO:0008285~negative regulation of cell population proliferation	27	396	6.81818181818182	0.00025496200127206	0.0109578234024972	0.98491821091398	1	0.490801852448722	0.953410687097476	0.0970843990148521
up	JCHAIN; IGKV3-20; IGHA1; IGHA2; LTF; CTSG; H2BFS; RNASE6;	GO:0019731~antibacterial humoral response	8	31	25.8064516129032	0.0002632327925931	0.0268617099714327	0.585429730727064	0.590957619371519	0.583561804834972	0.585429730727064	0.222788313921148
down	EREG; COCH; CCL5; FPR2; ADAM8; POLR3B;	GO:0045089~positive regulation of innate immune response	6	25	24	0.00028829875037095	0.012126949563476	1	1	0.512587104866141	0.953410687097476	0.107442652341449
down	NDUFA2; NDUFS6; NDUFA3; NDUFB8; NDUFV3; NDUFB11; NDUFA13; NDUFA12;	GO:0006120~mitochondrial electron transport, NADH to ubiquinone	8	49	16.3265306122449	0.00030045629637109	0.0125053073247508	1	1	0.51948893642563	0.953410687097476	0.110794835938202
up	TYROBP; CTLA4; IL10; FCGR2B; MNDA; CD300A;	GO:0030889~negative regulation of B cell proliferation	6	16	37.5	0.00030315118516266	0.0294550940613528	0.673905084616603	0.680574410690182	0.641164756619035	0.673905084616603	0.244297580060857
down	MAPT; RPS23; OGFOD1; BICD1; DDX6;	GO:0034063~stress granule assembly	5	16	31.25	0.00033806585761508	0.0132217778468998	1	1	0.540830998062478	0.953410687097476	0.117142639466304
down	SNAPIN; AP3M2; BLOC1S1; BLOC1S3; BLOC1S2;	GO:0048490~anterograde synaptic vesicle transport	5	16	31.25	0.00033806585761508	0.0132217778468998	1	1	0.540830998062478	0.953410687097476	0.117142639466304
down	RPL5; RPL11; RPL12; RPLP0; RPL24; RSL24D1;	GO:0000027~ribosomal large subunit assembly	6	26	23.0769230769231	0.00034581097033048	0.0132217778468998	1	1	0.545207494691992	0.953410687097476	0.117142639466304
down	EREG; DSCAM; FZD7; AR; CCL5; MIF;	GO:0042327~positive regulation of phosphorylation	6	26	23.0769230769231	0.00034581097033048	0.0132217778468998	1	1	0.545207494691992	0.953410687097476	0.117142639466304
down	TH; RACK1; KRT76; EN1; BLOC1S3; HPS5;	GO:0043473~pigmentation	6	26	23.0769230769231	0.00034581097033048	0.0132217778468998	1	1	0.545207494691992	0.953410687097476	0.117142639466304
down	NDUFA2; NDUFS6; NDUFA3; NDUFB8; NDUFV3; NDUFAF3; NDUFB11; NDUFA13; NDUFA12;	GO:0032981~mitochondrial respiratory chain complex I assembly	9	64	14.0625	0.00034776552758664	0.0132217778468998	1	1	0.546339643838613	0.953410687097476	0.117142639466304
down	NCF1; FLT4; CDC42; FOXC1; NCF4; CYFIP1; CYFIP2; FOXC2; NCKAP1;	GO:0048010~vascular endothelial growth factor receptor signaling pathway	9	64	14.0625	0.00034776552758664	0.0132217778468998	1	1	0.546339643838613	0.953410687097476	0.117142639466304
down	SOX1; LMX1B; EDF1; PFDN1; FZD7; SUPT3H; IGF2; ATF4; WT1; HOXD13; GATA4; SKOR1; ELAVL2; FOXC1; RLF; RUNX3; SIX1; NCOA2; TRIP4; JMJD1C; LRIF1; ZNF549; ZNF562; ZNF836; MTERF4; IGSF1; ZNF565; ASCC1; ZNF114; MAFA; ZNF398; ZNF473; ZNF274; ZNF778; ZNF285; TSC22D3; ZNF212; SAP30BP; LRRFIP2; ZNF280C; NFX1; ZNF438; YY1AP1; PFDN5; MLF1;	GO:0006355~regulation of transcription, DNA-templated	45	824	5.46116504854369	0.0003907806038389	0.0143069121072132	1	1	0.568585778585604	0.953410687097476	0.126756739241716
up	CD1A; CD1C; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	4	5	80	0.00040424182043863	0.0363009154753893	0.897821083194205	0.907522886884732	0.768463700653842	0.897821083194205	0.301076132575216
down	RPL5; RPL23; RPL11; CSNK2A1; TRIM39;	GO:2000059~negative regulation of ubiquitin-dependent protein catabolic process	5	17	29.4117647058824	0.00042665597976154	0.0152196159947458	1	1	0.583347587410239	0.953410687097476	0.13484313606934
down	SNU13; TAF9; ZNHIT6; PIH1D2;	GO:0000492~box C/D snoRNP assembly	4	9	44.4444444444444	0.0004749121217602	0.0159301887569651	1	1	0.599379742030278	0.953410687097476	0.14113868647588
down	USO1; VTI1A; SEC22B; VTI1B;	GO:0048280~vesicle fusion with Golgi apparatus	4	9	44.4444444444444	0.0004749121217602	0.0159301887569651	1	1	0.599379742030278	0.953410687097476	0.14113868647588
down	FZD7; WT1; BASP1; TCF15;	GO:0060231~mesenchymal to epithelial transition	4	9	44.4444444444444	0.0004749121217602	0.0159301887569651	1	1	0.599379742030278	0.953410687097476	0.14113868647588
down	FCMR; PRF1; NCF1; FOSL1; GNLY; CXCR2; LSP1; CX3CR1;	GO:0006968~cellular defense response	8	53	15.0943396226415	0.00048148042929707	0.0159301887569651	1	1	0.60162009764551	0.953410687097476	0.14113868647588
down	KIF1B; SNAPIN; BLOC1S1; LAMTOR1; BLOC1S2; VPS33A;	GO:0032418~lysosome localization	6	28	21.4285714285714	0.00048749439544582	0.0159301887569651	1	1	0.603566000001074	0.953410687097476	0.14113868647588
down	EREG; TGFA; IGF2; IL1A; EPGN; RGCC;	GO:0045840~positive regulation of mitotic nuclear division	6	28	21.4285714285714	0.00048749439544582	0.0159301887569651	1	1	0.603566000001074	0.953410687097476	0.14113868647588
down	S100A8; MPO; GNLY; S100A12; NLRP10; RNASE7;	GO:0050832~defense response to fungus	6	28	21.4285714285714	0.00048749439544582	0.0159301887569651	1	1	0.603566000001074	0.953410687097476	0.14113868647588
up	CCL2; FOLR2; CCR2; CCL14; CCL18; CCL19; CCL13; CCL11; XCL2;	GO:0002548~monocyte chemotaxis	9	44	20.4545454545455	0.00049033044866186	0.0423381483556114	1	1	0.857097624260946	0.999999965871281	0.351148333323583
down	RPL5; RPL11; COPS9;	GO:2000435~negative regulation of protein neddylation	3	3	100	0.00051233101510983	0.0164695677540186	1	1	0.611800862623471	0.953410687097476	0.145917490061841
down	RPS19; RPS6; RPS15; RPS24; EMG1;	GO:0042274~ribosomal small subunit biogenesis	5	18	27.7777777777778	0.00053167310570345	0.0168178836796117	1	1	0.617680764903827	0.953410687097476	0.149003508248245
down	MPV17; EIF6; FOXO1; PARL; STK17A;	GO:2000377~regulation of reactive oxygen species metabolic process	5	18	27.7777777777778	0.00053167310570345	0.0168178836796117	1	1	0.617680764903827	0.953410687097476	0.149003508248245
down	EBAG9; URI1; AGTR1; LAMTOR1; RASGRP2; NANOS1; ITCH; PAPPA2; EPB41L3;	GO:0001558~regulation of cell growth	9	69	13.0434782608696	0.00057122910256424	0.0178530783438635	1	1	0.629494471025794	0.953410687097476	0.158175151936111
down	ADRA2C; COMT; NTSR1; OPRD1; MGLL; SPX;	GO:0051930~regulation of sensory perception of pain	6	29	20.6896551724138	0.00057342967872298	0.0178530783438635	1	1	0.630199216916556	0.953410687097476	0.158175151936111
down	WT1; HOXA11; HOXD11; LHX1; SIX1; ADAMTS16; GREB1L;	GO:0001658~branching involved in ureteric bud morphogenesis	7	42	16.6666666666667	0.00063822320074191	0.0195891910860192	1	1	0.649663621571858	0.953410687097476	0.173556807215918
down	MGMT; ALKBH1; ALKBH2; ASCC1;	GO:0006307~DNA dealkylation involved in DNA repair	4	10	40	0.00064900961868197	0.0195891910860192	1	1	0.652785253147636	0.953410687097476	0.173556807215918
down	EREG; TGFA; NCF1; EPGN;	GO:0045741~positive regulation of epidermal growth factor-activated receptor activity	4	10	40	0.00064900961868197	0.0195891910860192	1	1	0.652785253147636	0.953410687097476	0.173556807215918
down	HOXD9; HOXD10; RUNX3; ISL2;	GO:0048935~peripheral nervous system neuron development	4	10	40	0.00064900961868197	0.0195891910860192	1	1	0.652785253147636	0.953410687097476	0.173556807215918
down	SCAMP3; SCFD1; SORL1; VAMP8; RABIF;	GO:0006892~post-Golgi vesicle-mediated transport	5	19	26.3157894736842	0.00065497189167573	0.0196076262823642	1	1	0.654316919784062	0.953410687097476	0.173720139831541
down	SRMS; LCK; PTK6; FER; HCK; FGR;	GO:0038083~peptidyl-tyrosine autophosphorylation	6	31	19.3548387096774	0.0007801961322793	0.0220349679073742	1	1	0.68661790068434	0.953410687097476	0.19522596212962
down	LEPROT; ABLIM3; ARIH2; UBL5; HPS4; TOMM7;	GO:1903955~positive regulation of protein targeting to mitochondrion	6	31	19.3548387096774	0.0007801961322793	0.0220349679073742	1	1	0.68661790068434	0.953410687097476	0.19522596212962
down	HOXB8; HOXD10; HOXA6; SIX1; OSR2; ALX4; HOXD9;	GO:0048704~embryonic skeletal system morphogenesis	7	44	15.9090909090909	0.00081638129735939	0.0228934159557378	1	1	0.694279794940245	0.953410687097476	0.202831661710603
down	CD247; FCER1G; SLC11A1;	GO:0032623~interleukin-2 production	3	4	75	0.00087641355133727	0.0242331411327803	1	1	0.705996645243634	0.953410687097476	0.214701392484745
down	RPL24; RSL24D1; EIF6;	GO:1902626~assembly of large subunit precursor of preribosome	3	4	75	0.00087641355133727	0.0242331411327803	1	1	0.705996645243634	0.953410687097476	0.214701392484745
down	PIAS1; RBX1; RACK1; ZFAND2A; FAM122A; PLK2; ARIH1; TRIB3; ARIH2;	GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process	9	74	12.1621621621622	0.00090051596497287	0.0245561387965705	1	1	0.710145491178788	0.953410687097476	0.217563095299296
down	IGF2BP3; ZFP36; CETN2; EIF5AL1; EIF5A2; SENP2; IGF2BP1;	GO:0051028~mRNA transport	7	45	15.5555555555556	0.00091905932441527	0.024890140881767	1	1	0.712307003688824	0.953410687097476	0.220522295363026
down	ACOT8; DOK2; SNAPIN; ASGR1; CALM1; ZFP36; IL12A; NUP214; CX3CR1; RBX1; SKP1; RACK1; NFX1; SLC20A1; KAT2B; KAT5; BICD1; PSMB7; RBM38; AZI2; TMEM134; XPO5; ITSN2; NDUFA13; VAPA; FBXW11; PILRA; NCKAP1;	GO:0016032~viral process	28	456	6.14035087719298	0.00092589316709701	0.0249046366170176	1	1	0.713161376680957	0.953410687097476	0.220650725042296
up	CD1C; CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	4	7	57.1428571428571	0.00098574727512723	0.0790358083093087	1	1	0.999999965871282	0.999999965871281	0.655515024596432
up	UGT1A9; UGT1A3; UGT1A8; UGT1A10;	GO:0052696~flavonoid glucuronidation	4	7	57.1428571428571	0.00098574727512723	0.0790358083093087	1	1	0.999999965871282	0.999999965871281	0.655515024596432
down	WNT10B; EREG; NKX2-8; AR; CDKN2B; ISL1; RUNX3; TINF2;	GO:0050680~negative regulation of epithelial cell proliferation	8	60	13.3333333333333	0.00100397130959551	0.0266422990479238	1	1	0.722690702157482	0.953410687097476	0.236046110293418
down	STX1B; EXOC6; SCFD2; SCFD1; VPS33A; VTI1B;	GO:0006904~vesicle docking involved in exocytosis	6	33	18.1818181818182	0.00104020551139949	0.0272382290865801	1	1	0.727103324884755	0.953410687097476	0.241325946218194
down	LSM1; DDX6; EXOSC7; EXOSC6; WDR61; EXOSC1;	GO:0043928~exonucleolytic catabolism of deadenylated mRNA	6	33	18.1818181818182	0.00104020551139949	0.0272382290865801	1	1	0.727103324884755	0.953410687097476	0.241325946218194
down	DKK1; EOMES; LHX1; DUSP1;	GO:0001706~endoderm formation	4	12	33.3333333333333	0.00112445591535482	0.0290594685576009	1	1	0.736830664147561	0.953410687097476	0.257461809428573
down	EDN2; ACADL; NTSR1; FOXO1; ADRB1;	GO:0001659~temperature homeostasis	5	22	22.7272727272727	0.00115409639059072	0.0292689377044682	1	1	0.740082083156556	0.953410687097476	0.259317669437334
down	LHX2; DYNLT1; SORL1; ARHGEF2; DLL3;	GO:0050768~negative regulation of neurogenesis	5	22	22.7272727272727	0.00115409639059072	0.0292689377044682	1	1	0.740082083156556	0.953410687097476	0.259317669437334
down	ITGB1BP1; EREG; TGFA; IGF2; IL1A; PPBP; FGF5;	GO:0051781~positive regulation of cell division	7	47	14.8936170212766	0.00115476840715656	0.0292689377044682	1	1	0.740206548987354	0.953410687097476	0.259317669437334
down	HCK; CCL5; CD6; PRKCE; IL18; CD14;	GO:0031663~lipopolysaccharide-mediated signaling pathway	6	34	17.6470588235294	0.00119282469281279	0.0296630744363633	1	1	0.744217331187978	0.953410687097476	0.262809651954318
down	TOR1A; MSX1; RPL11; SIX1; BANP; TOR1B;	GO:0034504~protein localization to nucleus	6	34	17.6470588235294	0.00119282469281279	0.0296630744363633	1	1	0.744217331187978	0.953410687097476	0.262809651954318
down	SNAPIN; GABARAPL2; VPS33A; VAMP8; VTI1B; UBQLN1;	GO:0097352~autophagosome maturation	6	34	17.6470588235294	0.00119282469281279	0.0296630744363633	1	1	0.744217331187978	0.953410687097476	0.262809651954318
up	ADAMDEC1; ADAM12; ECEL1; HP; HPR; LTF; CFI; CTSG; CTSE; CPA3; GZMH; KEL; DPP4; GGT5; MMP12; GZMK; CTSC; TMPRSS3; HABP2; MMEL1; ADAMTSL2; PRSS33; ADAMTS19; MMP19; ADAM33; ADAMTS10; KLK13; ADAMTS5; CAPN8; TPSAB1; CPA6; TPSB2; PGC; TPSD1; TPSG1; PRSS21;	GO:0006508~proteolysis	36	436	8.25688073394496	0.00124418830729767	0.0963173362028711	1	1	0.999999965871282	0.999999965871281	0.798846274374746
down	IGF2; RPS3; IL18; GPAM; TNFSF9;	GO:0042104~positive regulation of activated T cell proliferation	5	23	21.7391304347826	0.00137033983217072	0.0331919542778418	1	1	0.76190894668692	0.953410687097476	0.294074910210578
down	URI1; VDAC2; BCL2L1; PARL; NDUFA13;	GO:2001243~negative regulation of intrinsic apoptotic signaling pathway	5	23	21.7391304347826	0.00137033983217072	0.0331919542778418	1	1	0.76190894668692	0.953410687097476	0.294074910210578
down	LEPROTL1; LEPROT; TMEM50B;	GO:0032511~late endosome to vacuole transport via multivesicular body sorting pathway	3	5	60	0.00137077140906861	0.0331919542778418	1	1	0.762002551934429	0.953410687097476	0.294074910210578
down	PAX7; LHX1; LHX5; LHX3;	GO:0021527~spinal cord association neuron differentiation	4	13	30.7692307692308	0.00143546387999771	0.0331919542778418	1	1	0.768289286736871	0.953410687097476	0.294074910210578
down	CCR7; CDC42; CDC42EP3; C15orf62;	GO:0031274~positive regulation of pseudopodium assembly	4	13	30.7692307692308	0.00143546387999771	0.0331919542778418	1	1	0.768289286736871	0.953410687097476	0.294074910210578
down	WNT10B; FOXF2; DESI1; COMMD1;	GO:0032434~regulation of proteasomal ubiquitin-dependent protein catabolic process	4	13	30.7692307692308	0.00143546387999771	0.0331919542778418	1	1	0.768289286736871	0.953410687097476	0.294074910210578
down	GMPR; ADK; DGUOK; ADAL;	GO:0043101~purine-containing compound salvage	4	13	30.7692307692308	0.00143546387999771	0.0331919542778418	1	1	0.768289286736871	0.953410687097476	0.294074910210578
down	NCF1; CD52; SLC11A1; NCF4;	GO:0045730~respiratory burst	4	13	30.7692307692308	0.00143546387999771	0.0331919542778418	1	1	0.768289286736871	0.953410687097476	0.294074910210578
down	ADRB1; ADM; GMPR; METRNL; PCSK1N; UCP2;	GO:0009409~response to cold	6	36	16.6666666666667	0.00154886624760742	0.0351966502473547	1	1	0.779642756320688	0.953410687097476	0.311836165914271
down	ANXA7; GCA; RABIF; VAPA; VTI1B; USO1;	GO:0061025~membrane fusion	6	36	16.6666666666667	0.00154886624760742	0.0351966502473547	1	1	0.779642756320688	0.953410687097476	0.311836165914271
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.00156883060512758	0.117400823617047	1	1	0.999999965871282	0.999999965871281	0.973710593049076
down	PEX7; ACOT8; MPV17; PEX19; UBA52; ACOT4; ACOX2; DHRS4;	GO:0006625~protein targeting to peroxisome	8	65	12.3076923076923	0.00159969716593256	0.0359386511028257	1	1	0.78478593611617	0.953410687097476	0.318410163730798
down	PDCD6; CD5; CD3E; CD14; DAP3; CASP5; NDUFA13; DAPL1;	GO:0097190~apoptotic signaling pathway	8	65	12.3076923076923	0.00159969716593256	0.0359386511028257	1	1	0.78478593611617	0.953410687097476	0.318410163730798
up	IL2RA; IDO1; CTLA4; IL10; LILRB2; LILRB1; PDCD1LG2; CD80;	GO:0042130~negative regulation of T cell proliferation	8	43	18.6046511627907	0.00170181301857708	0.119847468343282	1	1	0.999999965871282	0.999999965871281	0.994002817702743
up	XCL2; CCL18; CCL2; CCL14; CCL19; CCL11; CCL13;	GO:0048247~lymphocyte chemotaxis	7	33	21.2121212121212	0.00170829353540536	0.119847468343282	1	1	0.999999965871282	0.999999965871281	0.994002817702743
down	S100A8; CDC42; CSNK2A1; TAF9; FXN; CSNK2A3; FAM122A; SLC25A33; N6AMT1;	GO:0030307~positive regulation of cell growth	9	82	10.9756097560976	0.00173399744080494	0.0385181229266445	1	1	0.791526000588148	0.953410687097476	0.341263832985416
down	OPRD1; CDC42; ISL1; SORL1; SOST; LCMT1;	GO:0031333~negative regulation of protein-containing complex assembly	6	37	16.2162162162162	0.00175460360221269	0.0385427924619388	1	1	0.792343775052173	0.953410687097476	0.341482400753854
down	HCK; FER; CCR7; PRKCE; NCKAP1; C15orf62; CDC42EP3;	GO:0030838~positive regulation of actin filament polymerization	7	51	13.7254901960784	0.00176652127449306	0.0385901940295335	1	1	0.792844013675533	0.953410687097476	0.34190237035304
down	SIRPB1; PSTPIP1; PRDM1; SLPI; S100A8; CD14; FGR; MIF; NCF1; CD6; CX3CR1; GZMM; S100A12; AKIRIN2; SDHAF4; TNFAIP8L2; IL34; NLRP10; ARHGEF2; ITCH; DEFB126; CD244; RNASE7; LY9; TREM1; POLR3B; MID2; IFNL1; FCER1G;	GO:0045087~innate immune response	29	505	5.74257425742574	0.00196475533242202	0.0422753045521148	1	1	0.800495811877302	0.953410687097476	0.374551805121864
down	BLOC1S1; KAT2B; KAT5;	GO:0018394~peptidyl-lysine acetylation	3	6	50	0.0020100549458264	0.0422753045521148	1	1	0.802191501229494	0.953410687097476	0.374551805121864
down	GAPVD1; SCFD1; SLC7A11;	GO:0051223~regulation of protein transport	3	6	50	0.0020100549458264	0.0422753045521148	1	1	0.802191501229494	0.953410687097476	0.374551805121864
down	EOMES; STK4; STK3;	GO:0060706~cell differentiation involved in embryonic placenta development	3	6	50	0.0020100549458264	0.0422753045521148	1	1	0.802191501229494	0.953410687097476	0.374551805121864
down	C1QL1; DKK1; EN1;	GO:0061743~motor learning	3	6	50	0.0020100549458264	0.0422753045521148	1	1	0.802191501229494	0.953410687097476	0.374551805121864
down	EIF3D; EIF3E; LARP6;	GO:1902416~positive regulation of mRNA binding	3	6	50	0.0020100549458264	0.0422753045521148	1	1	0.802191501229494	0.953410687097476	0.374551805121864
down	UPK2; KRT3; WT1; ANXA7; CES1; DLX6; SIX1; ACTL8;	GO:0030855~epithelial cell differentiation	8	68	11.7647058823529	0.00207322438689361	0.0433731705067584	1	1	0.804649645186833	0.953410687097476	0.384278705482491
up	UGT1A9; UGT1A3; UGT1A8; ADH1B; ADH1C; ADH1A;	GO:0042573~retinoic acid metabolic process	6	25	24	0.0021262055262592	0.144646406256118	1	1	0.999999965871282	0.999999965871281	1
down	HAX1; MME; PTPN2; PTPN6; CCR7; PTPN5; NLRP12;	GO:0071345~cellular response to cytokine stimulus	7	53	13.2075471698113	0.00215404063287405	0.0445920244103875	1	1	0.807765237327771	0.953410687097476	0.395077537912458
down	RGS10; RGS11; NLRP12; PTK6; BRAP; SRMS;	GO:0009968~negative regulation of signal transduction	6	39	15.3846153846154	0.00222748593143884	0.0451777409464858	1	1	0.810804879043739	0.953410687097476	0.400266883990732
down	DKK1; HOXD10; HOXA11; DLX6; SP8; HOXC10;	GO:0030326~embryonic limb morphogenesis	6	39	15.3846153846154	0.00222748593143884	0.0451777409464858	1	1	0.810804879043739	0.953410687097476	0.400266883990732
down	RBP4; HOXA11; LHX1; GREB1L;	GO:0060065~uterus development	4	15	26.6666666666667	0.00222803730009224	0.0451777409464858	1	1	0.810855169442773	0.953410687097476	0.400266883990732
down	MAPT; DYNLT1; CAMSAP2; SVBP;	GO:0061564~axon development	4	15	26.6666666666667	0.00222803730009224	0.0451777409464858	1	1	0.810855169442773	0.953410687097476	0.400266883990732
down	FFAR2; PIAS1; FOXO1; METRNL; GDF6; TMEM120A; ARL6; SENP2;	GO:0045444~fat cell differentiation	8	70	11.4285714285714	0.00244566833390225	0.049087170519033	1	1	0.819145251922607	0.953410687097476	0.434903746312782
down	PDCD5; LAMTOR5; KIF1B; PRDM1; DKK1; IL1A; CD3E; AR; ALOX12; ATF4; WT1; RPS3; MT3; RPL5; SLC11A1; WNT3; RPL23; RPL11; IL34; CAMK2N1; OSR2; RGCC; MED26;	GO:0010628~positive regulation of gene expression	23	374	6.14973262032086	0.00247154978110764	0.0493561001742405	1	1	0.819847341838545	0.953410687097476	0.437286416026836
down	ASTN1; DSCAM; C1QL1; TH; CHRNB4; CHRNA3; SLURP1; QRFP; APBA2;	GO:0007626~locomotory behavior	9	87	10.3448275862069	0.00251056898791235	0.0495024030232664	1	1	0.82095605904734	0.953410687097476	0.438582633683401
down	TEAD1; TJP1; STK4; STK3; AMOTL2;	GO:0035329~hippo signaling	5	27	18.5185185185185	0.00254147390331894	0.0495024030232664	1	1	0.82178203700057	0.953410687097476	0.438582633683401
down	POLR2I; POLR2J; POLR2K; POLR2F; POLR2G;	GO:0050434~positive regulation of viral transcription	5	27	18.5185185185185	0.00254147390331894	0.0495024030232664	1	1	0.82178203700057	0.953410687097476	0.438582633683401
down	IL1A; FGR; MIF; RGCC; CD14;	GO:0050715~positive regulation of cytokine secretion	5	27	18.5185185185185	0.00254147390331894	0.0495024030232664	1	1	0.82178203700057	0.953410687097476	0.438582633683401
down	TH; CD14; EEF1A2; CYFIP1; S100A13;	GO:0051602~response to electrical stimulus	5	27	18.5185185185185	0.00254147390331894	0.0495024030232664	1	1	0.82178203700057	0.953410687097476	0.438582633683401
down	ATP6V0E1; LAMTOR5; ATP6V1G1; RHEB; LAMTOR1; ATP6V1E2; UBQLN2; UBQLN1;	GO:0016241~regulation of macroautophagy	8	71	11.2676056338028	0.00265051885919954	0.0513732920062498	1	1	0.824548979886094	0.953410687097476	0.45515838288694
up	CYP2C9; CYP2C19; CYP4A11; CYP4A22;	GO:0097267~omega-hydroxylase P450 pathway	4	10	40	0.00268749250384703	0.177453549151076	1	1	0.999999965871282	0.999999965871281	1
down	ATP6V0E1; ATP6V1G1; IGF2; PTPN2; FOXO1; ATP6V1F; ATP6V1E2; FOXC2; IRS2;	GO:0008286~insulin receptor signaling pathway	9	88	10.2272727272727	0.00269463593308894	0.0514401326861854	1	1	0.825771620722224	0.953410687097476	0.455750579621905
down	MPHOSPH6; RRP15; RPF1; EIF6;	GO:0000460~maturation of 5.8S rRNA	4	16	25	0.00271901561239574	0.0514401326861854	1	1	0.826526315569274	0.953410687097476	0.455750579621905
down	EIF3D; EIF3H; EIF3E; EIF2S2;	GO:0001732~formation of cytoplasmic translation initiation complex	4	16	25	0.00271901561239574	0.0514401326861854	1	1	0.826526315569274	0.953410687097476	0.455750579621905
down	SYT7; STX1B; SYT3; RIMS4;	GO:0048791~calcium ion-regulated exocytosis of neurotransmitter	4	16	25	0.00271901561239574	0.0514401326861854	1	1	0.826526315569274	0.953410687097476	0.455750579621905
down	OXSR1; DUSP1; FOXC1; STK39;	GO:1990869~cellular response to chemokine	4	16	25	0.00271901561239574	0.0514401326861854	1	1	0.826526315569274	0.953410687097476	0.455750579621905
down	CALM1; CETN2; BCL2L1; PIN1; PLK3; PLK2;	GO:0032465~regulation of cytokinesis	6	41	14.6341463414634	0.00279045909118203	0.0516268310072585	1	1	0.82835225008852	0.953410687097476	0.457404694096349
down	CSNK2B; ADIPOR2; ADIPOR1;	GO:0033211~adiponectin-activated signaling pathway	3	7	42.8571428571429	0.00280722525709676	0.0516268310072585	1	1	0.828620826700346	0.953410687097476	0.457404694096349
down	S100A8; CX3CR1; HILPDA;	GO:0035425~autocrine signaling	3	7	42.8571428571429	0.00280722525709676	0.0516268310072585	1	1	0.828620826700346	0.953410687097476	0.457404694096349
down	AZGP1; SEC61G; BLOC1S3;	GO:0071806~protein transmembrane transport	3	7	42.8571428571429	0.00280722525709676	0.0516268310072585	1	1	0.828620826700346	0.953410687097476	0.457404694096349
down	WT1; BASP1; FOXC2;	GO:0072112~glomerular visceral epithelial cell differentiation	3	7	42.8571428571429	0.00280722525709676	0.0516268310072585	1	1	0.828620826700346	0.953410687097476	0.457404694096349
down	SOD2; ATF4; STK4;	GO:1905461~positive regulation of vascular associated smooth muscle cell apoptotic process	3	7	42.8571428571429	0.00280722525709676	0.0516268310072585	1	1	0.828620826700346	0.953410687097476	0.457404694096349
down	PSMC4; PSMD8; PSMC6; RBX1; SKP1; PSMB7; GPR132;	GO:0010972~negative regulation of G2/M transition of mitotic cell cycle	7	56	12.5	0.00285453176556627	0.0522537898196715	1	1	0.829994114658926	0.953410687097476	0.462959439530219
down	ITGB1BP1; GMFG; GSTP1; GNAQ; CAMK2N1; ITPRIP; TRIB3; CAMK2N2;	GO:0006469~negative regulation of protein kinase activity	8	72	11.1111111111111	0.00286852340000687	0.0522591836205272	1	1	0.830275014468636	0.953410687097476	0.46300722766252
down	EIF3H; EIF1B; EIF3E; ALKBH1; MIF4GD;	GO:0006446~regulation of translational initiation	5	28	17.8571428571429	0.00292175097223124	0.0522591836205272	1	1	0.83163856827311	0.953410687097476	0.46300722766252
down	IL1A; ATF4; FLT4; GATA4; ISL1;	GO:0010575~positive regulation of vascular endothelial growth factor production	5	28	17.8571428571429	0.00292175097223124	0.0522591836205272	1	1	0.83163856827311	0.953410687097476	0.46300722766252
down	MPO; PRDX6; HBB; PRDX5; HBD;	GO:0042744~hydrogen peroxide catabolic process	5	28	17.8571428571429	0.00292175097223124	0.0522591836205272	1	1	0.83163856827311	0.953410687097476	0.46300722766252
down	LTA; FTH1; GSTP1; C1QL4; MED31;	GO:0048147~negative regulation of fibroblast proliferation	5	28	17.8571428571429	0.00292175097223124	0.0522591836205272	1	1	0.83163856827311	0.953410687097476	0.46300722766252
down	WT1; FOXC1; VAX1; SLC25A25; MTERF4; FOXC2;	GO:0043010~camera-type eye development	6	42	14.2857142857143	0.00310887549458938	0.0543982053989164	1	1	0.835592028359977	0.953410687097476	0.481958586541626
down	SUPT3H; TAF12; TAF9; KAT2B; TADA1; SGF29;	GO:0043966~histone H3 acetylation	6	42	14.2857142857143	0.00310887549458938	0.0543982053989164	1	1	0.835592028359977	0.953410687097476	0.481958586541626
down	RTCA; DUSP11; RBMS1; DEDD2; SNRNP40; BICD1; LARP6;	GO:0006396~RNA processing	7	57	12.280701754386	0.00312301280363025	0.0543982053989164	1	1	0.835856125896144	0.953410687097476	0.481958586541626
down	SYT7; CD14; ANXA3; SLC11A1; NCF4; PIP5K1A; TYRO3;	GO:0006909~phagocytosis	7	57	12.280701754386	0.00312301280363025	0.0543982053989164	1	1	0.835856125896144	0.953410687097476	0.481958586541626
up	FGF10; RAMP3; DRD2; ADCYAP1; CHRNA7; SLAMF1; ANGPT1; SYT14P1; FFAR4; SCIMP; NPNT; CCL19; NOX4; IL26; CCL11; CCL14; CCL2; XCL2; CCL13; CCL18;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	20	209	9.56937799043062	0.00317259255151192	0.203499150804122	1	1	0.999999965871282	0.999999965871281	1
down	CPA1; DPEP1; ALOX5AP; DPEP2;	GO:0006691~leukotriene metabolic process	4	17	23.5294117647059	0.00327923908413241	0.0562216800446427	1	1	0.839200612141394	0.953410687097476	0.498114253009003
down	RPS19; RPS14; TSR3; SNU13;	GO:0030490~maturation of SSU-rRNA	4	17	23.5294117647059	0.00327923908413241	0.0562216800446427	1	1	0.839200612141394	0.953410687097476	0.498114253009003
down	FFAR2; CD14; NLRP10; CD244;	GO:2000484~positive regulation of interleukin-8 secretion	4	17	23.5294117647059	0.00327923908413241	0.0562216800446427	1	1	0.839200612141394	0.953410687097476	0.498114253009003
down	HOXC11; HOXA11; OSR2; FOXC2; GREB1L;	GO:0001656~metanephros development	5	29	17.2413793103448	0.00334145038201594	0.0562216800446427	1	1	0.840392658465458	0.953410687097476	0.498114253009003
down	PEX7; ALPL; MMP13; FOXC1; PHOSPHO1;	GO:0001958~endochondral ossification	5	29	17.2413793103448	0.00334145038201594	0.0562216800446427	1	1	0.840392658465458	0.953410687097476	0.498114253009003
down	RPA2; CETN2; RBX1; UBA52; GTF2H5;	GO:0006294~nucleotide-excision repair, preincision complex assembly	5	29	17.2413793103448	0.00334145038201594	0.0562216800446427	1	1	0.840392658465458	0.953410687097476	0.498114253009003
down	DEAF1; PRDM1; WT1; BCL2L1; RNF2;	GO:0007281~germ cell development	5	29	17.2413793103448	0.00334145038201594	0.0562216800446427	1	1	0.840392658465458	0.953410687097476	0.498114253009003
down	EN2; CXCR2; MSX1; OTX1; EN1;	GO:0030901~midbrain development	5	29	17.2413793103448	0.00334145038201594	0.0562216800446427	1	1	0.840392658465458	0.953410687097476	0.498114253009003
down	PTPN6; RAP2B; HBB; TYRO3; FERMT3; SLC7A11;	GO:0070527~platelet aggregation	6	43	13.953488372093	0.00345361767507735	0.057862730030745	1	1	0.842682712718873	0.953410687097476	0.512653668894987
down	SEC22B; NCF1; PSMC4; PSMD8; PSMC6; NCF4; PSMB7; VAMP8;	GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent	8	75	10.6666666666667	0.00360713388612532	0.060179777998901	1	1	0.845956005503586	0.953410687097476	0.533182308681766
down	DPEP1; CBS; MTRR;	GO:0050667~homocysteine metabolic process	3	8	37.5	0.00377366334944951	0.0606299211854155	1	1	0.849274857294768	0.953410687097476	0.537170498592131
down	PRKCB; PRKCH; NFAM1;	GO:0050861~positive regulation of B cell receptor signaling pathway	3	8	37.5	0.00377366334944951	0.0606299211854155	1	1	0.849274857294768	0.953410687097476	0.537170498592131
down	NTSR1; PTH1R; CD244;	GO:0060732~positive regulation of inositol phosphate biosynthetic process	3	8	37.5	0.00377366334944951	0.0606299211854155	1	1	0.849274857294768	0.953410687097476	0.537170498592131
down	CCL5; CD27; SLC46A2;	GO:0070233~negative regulation of T cell apoptotic process	3	8	37.5	0.00377366334944951	0.0606299211854155	1	1	0.849274857294768	0.953410687097476	0.537170498592131
down	WT1; BASP1; SIX1;	GO:0072075~metanephric mesenchyme development	3	8	37.5	0.00377366334944951	0.0606299211854155	1	1	0.849274857294768	0.953410687097476	0.537170498592131
down	MEFV; PTPN2; FPR2; NLRP12; ISL1; TYRO3; METRNL; FNDC4; TNFAIP8L2;	GO:0050728~negative regulation of inflammatory response	9	93	9.67741935483871	0.00378097565811253	0.0606299211854155	1	1	0.84966169513971	0.953410687097476	0.537170498592131
down	TIMM17B; MTERF4; TOMM7; FIS1; TIMM9;	GO:0006626~protein targeting to mitochondrion	5	30	16.6666666666667	0.00380278716590365	0.0606299211854155	1	1	0.850052344194946	0.953410687097476	0.537170498592131
down	HCK; LHX2; TCF15; FOXC2; HES7;	GO:0007498~mesoderm development	5	30	16.6666666666667	0.00380278716590365	0.0606299211854155	1	1	0.850052344194946	0.953410687097476	0.537170498592131
down	ASGR1; OST4; DAD1; MGAT5; MCFD2;	GO:0018279~protein N-linked glycosylation via asparagine	5	30	16.6666666666667	0.00380278716590365	0.0606299211854155	1	1	0.850052344194946	0.953410687097476	0.537170498592131
down	UBA52; PDCD6IP; PCSK5; CHMP4C; UBAP1;	GO:0019058~viral life cycle	5	30	16.6666666666667	0.00380278716590365	0.0606299211854155	1	1	0.850052344194946	0.953410687097476	0.537170498592131
down	RPS19; RPS14; RPS5; RPS15;	GO:0000028~ribosomal small subunit assembly	4	18	22.2222222222222	0.00391314644065255	0.061643749108925	1	1	0.852479524111747	0.953410687097476	0.546152836693689
down	PRDM1; TH; GNGT1; RDH13;	GO:0042462~eye photoreceptor cell development	4	18	22.2222222222222	0.00391314644065255	0.061643749108925	1	1	0.852479524111747	0.953410687097476	0.546152836693689
down	CCL5; FPR2; MOSPD2; S100A14;	GO:0090026~positive regulation of monocyte chemotaxis	4	18	22.2222222222222	0.00391314644065255	0.061643749108925	1	1	0.852479524111747	0.953410687097476	0.546152836693689
up	COL6A6; COL6A5; ISLR; ADAM12; HAPLN1; CCL2; ENG; VCAM1; DPP4; COL15A1; CXCR3; CCL11; LGALS4; CNTNAP1; CLDN10; TNFAIP6; DPT; SLAMF1; LY6D; ADGRE1; HABP2; COL19A1; OMD; STAB1; SIRPG; CD300A; SIGLEC6; SIGLEC10; PCDHB5; PCDHGB4; SIGLEC8; PCDHA4; SIGLEC7; ICAM3; PCDHGC4;	GO:0007155~cell adhesion	35	454	7.70925110132159	0.00403024593630552	0.242714668223162	1	1	0.999999965871282	0.999999965871281	1
down	ATP6V1G1; FTH1; ALAS2; SLC11A1; SKP1; NEDD8; FXN;	GO:0006879~cellular iron ion homeostasis	7	60	11.6666666666667	0.00404496001459798	0.0632164897143099	1	1	0.855059197007613	0.953410687097476	0.56008704341263
down	CXCR2; AGTR1; OPRD1; CX3CR1; PTH1R; ADRA1B; FPR2;	GO:0007200~phospholipase C-activating G protein-coupled receptor signaling pathway	7	60	11.6666666666667	0.00404496001459798	0.0632164897143099	1	1	0.855059197007613	0.953410687097476	0.56008704341263
up	CNR2; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.00410831064253014	0.242714668223162	1	1	0.999999965871282	0.999999965871281	1
up	LTF; CLDN18; LILRB1;	GO:2001205~negative regulation of osteoclast development	3	5	60	0.00410831064253014	0.242714668223162	1	1	0.999999965871282	0.999999965871281	1
down	TXNL1; MPO; NCF1; GLRX; SLC11A1; NCF4; PRDX6; PRDX5;	GO:0045454~cell redox homeostasis	8	77	10.3896103896104	0.00417585592618452	0.0647503307142494	1	1	0.857806200037265	0.953410687097476	0.573676606430185
up	CCL11; CCL13; CCL18; XCL2; CCL2;	GO:0048245~eosinophil chemotaxis	5	20	25	0.00429326144134445	0.244855511513331	1	1	0.999999965871282	0.999999965871281	1
down	CDKN2B; BCL2L1; MAD2L1BP; PLK3; PLK2;	GO:0007093~mitotic cell cycle checkpoint	5	31	16.1290322580645	0.00430796732028671	0.0662789991611426	1	1	0.860737359694603	0.953410687097476	0.587220341532337
down	DEAF1; RBP4; PAX7; HSD17B7; PCSK5;	GO:0048706~embryonic skeletal system development	5	31	16.1290322580645	0.00430796732028671	0.0662789991611426	1	1	0.860737359694603	0.953410687097476	0.587220341532337
down	AR; HOXD9; HOXD10; HOXA11; SNU13; SPAG1; DEFB126;	GO:0007338~single fertilization	7	61	11.4754098360656	0.00439392593166099	0.0673394695108045	1	1	0.86227788394633	0.953410687097476	0.596615923372663
up	JCHAIN; PIGR; IGKC; IGHG3; IGHA1; IGHA2; LTF;	GO:0001895~retina homeostasis	7	40	17.5	0.00440435972280984	0.244855511513331	1	1	0.999999965871282	0.999999965871281	1
up	F13A1; IL2RA; IGHG4; FCER2; CCL2; OSM; VCAM1; IL10; CD80; IL13; FLT3; CCR2; FASLG; CCL11; CCR5; IL5RA; IRF4; BATF; IL31RA; IL22RA2; CCL19; IL26; IL19; IL20RA;	GO:0019221~cytokine-mediated signaling pathway	24	278	8.63309352517986	0.00447174876260426	0.244855511513331	1	1	0.999999965871282	0.999999965871281	1
down	CNOT1; IGF2BP3; RPS3; RGS2; RACK1; NANOS1; IGF2BP1; MALSU1;	GO:0017148~negative regulation of translation	8	78	10.2564102564103	0.00448489584609946	0.0679435945420584	1	1	0.864415510621205	0.953410687097476	0.601968365498692
down	HCK; AGTR1; XIAP; BST1; SETD6; MGLL; STK39; CASP5;	GO:0050727~regulation of inflammatory response	8	78	10.2564102564103	0.00448489584609946	0.0679435945420584	1	1	0.864415510621205	0.953410687097476	0.601968365498692
down	S100A8; ZP3; AGTR1; NLRP12; S100A12; IL18; NLRP10; NFKBIZ;	GO:0050729~positive regulation of inflammatory response	8	78	10.2564102564103	0.00448489584609946	0.0679435945420584	1	1	0.864415510621205	0.953410687097476	0.601968365498692
down	RPLP1; SLC11A1; PPP2R3C; RGCC; GPRC5D; STK4; STK3; OXSR1; STK39;	GO:0032147~activation of protein kinase activity	9	96	9.375	0.00458097827781134	0.0684920996972115	1	1	0.866085136189747	0.953410687097476	0.60682802524941
down	ITGB2; GSTP1; MAPT; FPR2;	GO:0032930~positive regulation of superoxide anion generation	4	19	21.0526315789474	0.00462503556377225	0.0684920996972115	1	1	0.86723154576176	0.953410687097476	0.60682802524941
down	SELL; ADD2; CX3CR1; SELPLG;	GO:0050901~leukocyte tethering or rolling	4	19	21.0526315789474	0.00462503556377225	0.0684920996972115	1	1	0.86723154576176	0.953410687097476	0.60682802524941
down	ITGB1BP1; AGTR1; FOXC1; FOXC2;	GO:0097746~regulation of blood vessel diameter	4	19	21.0526315789474	0.00462503556377225	0.0684920996972115	1	1	0.86723154576176	0.953410687097476	0.60682802524941
down	AR; VAMP8; VTI1B; STX8;	GO:1903076~regulation of protein localization to plasma membrane	4	19	21.0526315789474	0.00462503556377225	0.0684920996972115	1	1	0.86723154576176	0.953410687097476	0.60682802524941
down	RHOD; GMFG; ABL2; ARHGDIB;	GO:2000249~regulation of actin cytoskeleton reorganization	4	19	21.0526315789474	0.00462503556377225	0.0684920996972115	1	1	0.86723154576176	0.953410687097476	0.60682802524941
down	CA1; SOD2; RPLP0; MIF; IL12A; CDC42;	GO:0035722~interleukin-12-mediated signaling pathway	6	46	13.0434782608696	0.00465876214097505	0.0687341250202065	1	1	0.867815109670405	0.953410687097476	0.608972327285158
down	GNLY; RPS19; RPL30; S100A12; DEFB126; RNASE7; PPBP;	GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide	7	62	11.2903225806452	0.00476514416488749	0.0690331175262237	1	1	0.870221410231979	0.953410687097476	0.61162134859992
down	HDAC3; LAMTOR5; RHEB; LAMTOR1; MIOS;	GO:0032008~positive regulation of TOR signaling	5	32	15.625	0.0048591815683019	0.0690331175262237	1	1	0.872105588973589	0.953410687097476	0.61162134859992
down	ACOT8; PEX19; FIS1;	GO:0016559~peroxisome fission	3	9	33.3333333333333	0.00491927364933131	0.0690331175262237	1	1	0.8734017119296	0.953410687097476	0.61162134859992
down	UQCC3; UQCC2; SLC25A33;	GO:0034551~mitochondrial respiratory chain complex III assembly	3	9	33.3333333333333	0.00491927364933131	0.0690331175262237	1	1	0.8734017119296	0.953410687097476	0.61162134859992
down	FXN; ISCA2; LYRM4;	GO:0044281~small molecule metabolic process	3	9	33.3333333333333	0.00491927364933131	0.0690331175262237	1	1	0.8734017119296	0.953410687097476	0.61162134859992
down	STK4; STK3; FXN;	GO:0046621~negative regulation of organ growth	3	9	33.3333333333333	0.00491927364933131	0.0690331175262237	1	1	0.8734017119296	0.953410687097476	0.61162134859992
down	CNOT1; CYP26A1; CYP26C1;	GO:0048387~negative regulation of retinoic acid receptor signaling pathway	3	9	33.3333333333333	0.00491927364933131	0.0690331175262237	1	1	0.8734017119296	0.953410687097476	0.61162134859992
down	S100A12; NOX5; S100A13;	GO:0050663~cytokine secretion	3	9	33.3333333333333	0.00491927364933131	0.0690331175262237	1	1	0.8734017119296	0.953410687097476	0.61162134859992
down	BLOC1S1; BLOC1S3; BLOC1S2;	GO:0060155~platelet dense granule organization	3	9	33.3333333333333	0.00491927364933131	0.0690331175262237	1	1	0.8734017119296	0.953410687097476	0.61162134859992
down	TOR1A; PEX19; TIMM9;	GO:0072321~chaperone-mediated protein transport	3	9	33.3333333333333	0.00491927364933131	0.0690331175262237	1	1	0.8734017119296	0.953410687097476	0.61162134859992
down	RPL5; RPL23; RPL11;	GO:1904667~negative regulation of ubiquitin protein ligase activity	3	9	33.3333333333333	0.00491927364933131	0.0690331175262237	1	1	0.8734017119296	0.953410687097476	0.61162134859992
down	DKK1; HTRA3; SKOR1; RBPMS2; SORL1; SOST;	GO:0030514~negative regulation of BMP signaling pathway	6	47	12.7659574468085	0.00512179928490242	0.0695696771066514	1	1	0.87749608709528	0.953410687097476	0.616375172647643
down	PSMC4; PSMD8; PSMC6; SKP1; ANAPC16; PSMB7; ANAPC11; ANAPC7;	GO:1901990~regulation of mitotic cell cycle phase transition	8	80	10	0.00515537206008232	0.0695696771066514	1	1	0.878210328096404	0.953410687097476	0.616375172647643
down	PDCD6; IL1A; MAPT; HSPA6; HIKESHI; ZFAND1; HSP90AA4P;	GO:0034605~cellular response to heat	7	63	11.1111111111111	0.00515948040326464	0.0695696771066514	1	1	0.878210328096404	0.953410687097476	0.616375172647643
down	POLR2I; POLR2J; POLR2K; POLR2F; POLR2G; FOXD3; NR2E1;	GO:0035019~somatic stem cell population maintenance	7	63	11.1111111111111	0.00515948040326464	0.0695696771066514	1	1	0.878210328096404	0.953410687097476	0.616375172647643
up	TYROBP; KLRC2; MNDA; CCR2; CCR5; TRAT1; LILRB2; KIR2DL4;	GO:0006968~cellular defense response	8	53	15.0943396226415	0.00533299901088857	0.273081115210384	1	1	0.999999965871282	0.999999965871281	1
down	CYFIP1; NCKAP1; CYFIP2; CDC42;	GO:0030031~cell projection assembly	4	20	20	0.00541904829821949	0.0714230565705328	1	1	0.883489717873943	0.953410687097476	0.632795790574045
down	MSX1; RPL38; SIX1; OSR2;	GO:0042474~middle ear morphogenesis	4	20	20	0.00541904829821949	0.0714230565705328	1	1	0.883489717873943	0.953410687097476	0.632795790574045
down	ZFAND5; FGR; HOXD8; TCF15; TIPARP;	GO:0048705~skeletal system morphogenesis	5	33	15.1515151515152	0.00545859936715209	0.0717053219193335	1	1	0.884293097478639	0.953410687097476	0.635296612201157
down	PSMC4; PSMD8; PSMC6; UBA52; ANAPC16; PSMB7; ANAPC11; ANAPC7;	GO:0031145~anaphase-promoting complex-dependent catabolic process	8	81	9.87654320987654	0.00551804008693779	0.0722461274958676	1	1	0.885913927465671	0.953410687097476	0.640088055031832
down	CD3E; LHX1; EN1; FOXC1; CDK5R2; GBX2;	GO:0021549~cerebellum development	6	48	12.5	0.00561767814458725	0.0728272110940917	1	1	0.887593146844785	0.953410687097476	0.645236354090759
down	FZD7; FER; TYRO3; FERMT3; RADIL; LAMB4;	GO:0034446~substrate adhesion-dependent cell spreading	6	48	12.5	0.00561767814458725	0.0728272110940917	1	1	0.887593146844785	0.953410687097476	0.645236354090759
down	RHOD; CCL5; IL12A; CCR7; ADAM8; APBB1IP;	GO:0045785~positive regulation of cell adhesion	6	48	12.5	0.00561767814458725	0.0728272110940917	1	1	0.887593146844785	0.953410687097476	0.645236354090759
up	CXCL13; LILRA1; TRPA1; IL2RA; CD3D; CD3G; CCL2; EDNRB; KLRC1; VIPR2; GLP1R; GIPR; CXCR3; CCR5; ADGRE1; LILRB2; CLEC1A; ADGRE3; CD80; TRBV28; TRBV7-2; TRBV20-1; PDCD1LG2;	GO:0007166~cell surface receptor signaling pathway	23	268	8.58208955223881	0.00565482678750406	0.273081115210384	1	1	0.999999965871282	0.999999965871281	1
up	JCHAIN; IGKV3-20; IGHA1; IGHA2;	GO:0003094~glomerular filtration	4	13	30.7692307692308	0.00574624960348125	0.273081115210384	1	1	0.999999965871282	0.999999965871281	1
down	LCE2B; KRT34; SPRR2D; SPRR2B; KRT2; KRT32; CST6; SPRR2G;	GO:0008544~epidermis development	8	82	9.75609756097561	0.00589982356345176	0.0759866526706457	1	1	0.893852751243159	0.953410687097476	0.673228453928067
up	CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	3	6	50	0.00596034505358967	0.273081115210384	1	1	0.999999965871282	0.999999965871281	1
up	IL10; ANGPT1; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	3	6	50	0.00596034505358967	0.273081115210384	1	1	0.999999965871282	0.999999965871281	1
up	UGT1A9; UGT1A10; UGT1A8;	GO:0051552~flavone metabolic process	3	6	50	0.00596034505358967	0.273081115210384	1	1	0.999999965871282	0.999999965871281	1
up	FCGR2B; TMEM176B; LILRB1;	GO:2001199~negative regulation of dendritic cell differentiation	3	6	50	0.00596034505358967	0.273081115210384	1	1	0.999999965871282	0.999999965871281	1
down	PRDM1; PNMT; COMT; SETD9; MTRR; TRMT112; N6AMT1;	GO:0032259~methylation	7	65	10.7692307692308	0.00602099176672866	0.0770177870826877	1	1	0.896747114078702	0.953410687097476	0.682364124491421
down	DKK1; MT3; HBB; ACOX2; SAP30BP;	GO:0010942~positive regulation of cell death	5	34	14.7058823529412	0.00610836316948227	0.0770177870826877	1	1	0.897929385913893	0.953410687097476	0.682364124491421
down	MAPT; NCF1; FER; PRDX5; MPV17;	GO:0034614~cellular response to reactive oxygen species	5	34	14.7058823529412	0.00610836316948227	0.0770177870826877	1	1	0.897929385913893	0.953410687097476	0.682364124491421
down	PPP1R15A; ATF4; TRIB3; CHAC1; TMEM117;	GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	5	34	14.7058823529412	0.00610836316948227	0.0770177870826877	1	1	0.897929385913893	0.953410687097476	0.682364124491421
down	MEFV; FOXO1; KAT5; PLEKHF1; PLK2; MID2;	GO:0010508~positive regulation of autophagy	6	49	12.2448979591837	0.00614770538292009	0.0770177870826877	1	1	0.898753259747782	0.953410687097476	0.682364124491421
down	HOXC11; HOXA11; SIX1;	GO:0001759~organ induction	3	10	30	0.00625258210762336	0.0770177870826877	1	1	0.900824119793284	0.953410687097476	0.682364124491421
down	TH; ANXA7; PAPPA2;	GO:0009651~response to salt stress	3	10	30	0.00625258210762336	0.0770177870826877	1	1	0.900824119793284	0.953410687097476	0.682364124491421
down	EIF6; ADIPOR2; ADIPOR1;	GO:0042304~regulation of fatty acid biosynthetic process	3	10	30	0.00625258210762336	0.0770177870826877	1	1	0.900824119793284	0.953410687097476	0.682364124491421
down	WNT10B; PSMC6; PSMC4;	GO:0045899~positive regulation of RNA polymerase II transcriptional preinitiation complex assembly	3	10	30	0.00625258210762336	0.0770177870826877	1	1	0.900824119793284	0.953410687097476	0.682364124491421
down	SYT7; HCK; FGR;	GO:0050764~regulation of phagocytosis	3	10	30	0.00625258210762336	0.0770177870826877	1	1	0.900824119793284	0.953410687097476	0.682364124491421
down	RBP4; LHX1; TYRO3;	GO:0060068~vagina development	3	10	30	0.00625258210762336	0.0770177870826877	1	1	0.900824119793284	0.953410687097476	0.682364124491421
down	HOXC11; HOXA11; OSR2;	GO:0060272~embryonic skeletal joint morphogenesis	3	10	30	0.00625258210762336	0.0770177870826877	1	1	0.900824119793284	0.953410687097476	0.682364124491421
down	PDCD6; FOXC1; CYP26C1; FOXC2;	GO:0014032~neural crest cell development	4	21	19.047619047619	0.00629915731164965	0.0771110464714016	1	1	0.901884804206833	0.953410687097476	0.683190386365993
down	PIN1; TRIB3; DCUN1D3; DCUN1D5;	GO:0051443~positive regulation of ubiquitin-protein transferase activity	4	21	19.047619047619	0.00629915731164965	0.0771110464714016	1	1	0.901884804206833	0.953410687097476	0.683190386365993
down	MSX1; DLX6; FOXF2; VAX1; TIPARP; OSR2; ALX4;	GO:0060021~roof of mouth development	7	66	10.6060606060606	0.00648991695177104	0.0792010235410576	1	1	0.906305808149024	0.953410687097476	0.701707217702784
down	TOR1A; OXSR1; MPO; RPS3; PRDX6; PRDX5; NDUFA12; MSRA; ATOX1;	GO:0006979~response to oxidative stress	9	102	8.82352941176471	0.00657092251878544	0.0796976307953301	1	1	0.90745789180345	0.953410687097476	0.706107071127733
down	KPNA4; MB; FOSL1; AREG; DUSP1; HBB;	GO:0042542~response to hydrogen peroxide	6	50	12	0.00671318320050962	0.0806806272790731	1	1	0.91103436019154	0.953410687097476	0.714816248064838
down	MAPT; CX3CR1; RASGRF1; PLK2; JPH3; RIMS4;	GO:0048167~regulation of synaptic plasticity	6	50	12	0.00671318320050962	0.0806806272790731	1	1	0.91103436019154	0.953410687097476	0.714816248064838
down	CSPG5; PRKCB; PREPL; APBA2; RIMS4; SNAPIN;	GO:2000300~regulation of synaptic vesicle exocytosis	6	50	12	0.00671318320050962	0.0806806272790731	1	1	0.91103436019154	0.953410687097476	0.714816248064838
down	PFKFB2; GJD3; MAFA; GPAM; EIF2B3; EIF2B4; IRS2;	GO:0009749~response to glucose	7	67	10.4477611940298	0.00698545796056327	0.0829444467749765	1	1	0.916103708777662	0.953410687097476	0.734873292896186
up	P2RY10; GPR171; P2RY13; P2RY12;	GO:0035589~G protein-coupled purinergic nucleotide receptor signaling pathway	4	14	28.5714285714286	0.00713202824905079	0.302101951304133	1	1	0.999999965871282	0.999999965871281	1
up	UGT1A9; UGT1A4; UGT1A3; UGT1A10;	GO:0052695~cellular glucuronidation	4	14	28.5714285714286	0.00713202824905079	0.302101951304133	1	1	0.999999965871282	0.999999965871281	1
down	USO1; RABIF; RASGRF1; RUNDC3A; KNDC1; DOCK3; SH2D3C; RHEB;	GO:0007264~small GTPase mediated signal transduction	8	85	9.41176470588235	0.00716614665278381	0.0847853637167253	1	1	0.920152146884634	0.953410687097476	0.751183495055971
down	CETN2; RBX1; UBA52; GTF2H5;	GO:0000717~nucleotide-excision repair, DNA duplex unwinding	4	22	18.1818181818182	0.00726915485583457	0.0847853637167253	1	1	0.922978414997048	0.953410687097476	0.751183495055971
down	SOD2; BCL2L1; PMAIP1; FIS1;	GO:0001836~release of cytochrome c from mitochondria	4	22	18.1818181818182	0.00726915485583457	0.0847853637167253	1	1	0.922978414997048	0.953410687097476	0.751183495055971
down	SNAPIN; BLOC1S1; BLOC1S3; BLOC1S2;	GO:0032438~melanosome organization	4	22	18.1818181818182	0.00726915485583457	0.0847853637167253	1	1	0.922978414997048	0.953410687097476	0.751183495055971
down	PFKFB2; PFKFB3; FGGY; RBKS;	GO:0046835~carbohydrate phosphorylation	4	22	18.1818181818182	0.00726915485583457	0.0847853637167253	1	1	0.922978414997048	0.953410687097476	0.751183495055971
down	NDUFS6; BCL2L1; PANK2; FIS1;	GO:0070584~mitochondrion morphogenesis	4	22	18.1818181818182	0.00726915485583457	0.0847853637167253	1	1	0.922978414997048	0.953410687097476	0.751183495055971
down	POLR2K; POLR2F; LRRFIP1; POLR3GL; POLR3B; CD14;	GO:0032481~positive regulation of type I interferon production	6	51	11.7647058823529	0.00731540699019839	0.0848243965960248	1	1	0.922978414997048	0.953410687097476	0.751529319540397
down	TIPRL; PPP1R15A; URI1; PPP1R2; FAM122A; STYXL1;	GO:0032515~negative regulation of phosphoprotein phosphatase activity	6	51	11.7647058823529	0.00731540699019839	0.0848243965960248	1	1	0.922978414997048	0.953410687097476	0.751529319540397
down	ARPC2; ARPC3; PSEN2; AP2S1; CDC42; ARPC1A; PSENEN; EPHA6;	GO:0048013~ephrin receptor signaling pathway	8	86	9.30232558139535	0.0076306851482012	0.0876507078612103	1	1	0.930533785198552	0.953410687097476	0.776569943077633
down	ITGB2; S100A8; ADAM8;	GO:0002523~leukocyte migration involved in inflammatory response	3	11	27.2727272727273	0.00778082915004674	0.0876507078612103	1	1	0.933405616562939	0.953410687097476	0.776569943077633
down	SLC25A33; MTERF4; MTERF3;	GO:0006390~mitochondrial transcription	3	11	27.2727272727273	0.00778082915004674	0.0876507078612103	1	1	0.933405616562939	0.953410687097476	0.776569943077633
down	SETD3; SETD6; SETD7;	GO:0018026~peptidyl-lysine monomethylation	3	11	27.2727272727273	0.00778082915004674	0.0876507078612103	1	1	0.933405616562939	0.953410687097476	0.776569943077633
down	LHX2; PDCD6IP; PDZD11;	GO:0045199~maintenance of epithelial cell apical/basal polarity	3	11	27.2727272727273	0.00778082915004674	0.0876507078612103	1	1	0.933405616562939	0.953410687097476	0.776569943077633
down	CALM1; GCHFR; PTS;	GO:0051186~cofactor metabolic process	3	11	27.2727272727273	0.00778082915004674	0.0876507078612103	1	1	0.933405616562939	0.953410687097476	0.776569943077633
down	BCL2L1; STK4; STK3;	GO:0097284~hepatocyte apoptotic process	3	11	27.2727272727273	0.00778082915004674	0.0876507078612103	1	1	0.933405616562939	0.953410687097476	0.776569943077633
down	STK4; STK3; PMAIP1;	GO:1902043~positive regulation of extrinsic apoptotic signaling pathway via death domain receptors	3	11	27.2727272727273	0.00778082915004674	0.0876507078612103	1	1	0.933405616562939	0.953410687097476	0.776569943077633
down	DNAJC6; SMAP1; BMP2K;	GO:2000369~regulation of clathrin-dependent endocytosis	3	11	27.2727272727273	0.00778082915004674	0.0876507078612103	1	1	0.933405616562939	0.953410687097476	0.776569943077633
down	SERPINA1; CHGB; PSMC4; PSMD8; RABGGTB; PSMC6; RBX1; SKP1; NEDD8; NOTUM; AMTN; DCUN1D3; FBXL16; COMMD1; LMO7; UBE2F; PSMB7; FBXO10; FBXW11; ASB3;	GO:0043687~post-translational protein modification	20	344	5.81395348837209	0.00799047023976907	0.0884128604695433	1	1	0.935845892684672	0.953410687097476	0.78332248190033
down	CCL5; IL12A; ISL1; PTK6; IL18; IFNL1; ARL2BP;	GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein	7	69	10.1449275362319	0.0080598962564431	0.0884128604695433	1	1	0.937102272470119	0.953410687097476	0.78332248190033
down	PDCD6; S100A8; LCK; MAPT; NLRP12; RACK1; PMAIP1; CASP5;	GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process	8	87	9.19540229885057	0.00811749676684315	0.0884128604695433	1	1	0.938383779851275	0.953410687097476	0.78332248190033
up	SPI1; LY6D; FLT3;	GO:0030098~lymphocyte differentiation	3	7	42.8571428571429	0.00823617221844719	0.320352262818121	1	1	0.999999965871282	0.999999965871281	1
up	FCGR2B; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	3	7	42.8571428571429	0.00823617221844719	0.320352262818121	1	1	0.999999965871282	0.999999965871281	1
up	HP; GZMA; GZMK;	GO:0051354~negative regulation of oxidoreductase activity	3	7	42.8571428571429	0.00823617221844719	0.320352262818121	1	1	0.999999965871282	0.999999965871281	1
up	JCHAIN; IGHA1; IGHA2;	GO:0060267~positive regulation of respiratory burst	3	7	42.8571428571429	0.00823617221844719	0.320352262818121	1	1	0.999999965871282	0.999999965871281	1
up	SIGLEC6; CXCL13; C1QA; PGR; GJB1; ADCYAP1; VIPR2; FASLG; CCR5; CCL18; CXCL6; TNFAIP6; LILRB2; FCRL2; CCL13; IL26; STAB1; SIRPG; DRD2; ADRA2A;	GO:0007267~cell-cell signaling	20	230	8.69565217391304	0.00827636135565746	0.320352262818121	1	1	0.999999965871282	0.999999965871281	1
down	DSCAM; LHX1; RDH13; ARL6;	GO:0010842~retina layer formation	4	23	17.3913043478261	0.00833264328446714	0.0884128604695433	1	1	0.941588691144787	0.953410687097476	0.78332248190033
down	ARPC2; ARPC3; ARPC1A; ARPC5L;	GO:0034314~Arp2/3 complex-mediated actin nucleation	4	23	17.3913043478261	0.00833264328446714	0.0884128604695433	1	1	0.941588691144787	0.953410687097476	0.78332248190033
down	ARHGDIB; RASGRF1; ARHGEF25; ARHGEF2;	GO:0035023~regulation of Rho protein signal transduction	4	23	17.3913043478261	0.00833264328446714	0.0884128604695433	1	1	0.941588691144787	0.953410687097476	0.78332248190033
down	HOXA11; ADM; ALKBH1; DMBX1;	GO:0048589~developmental growth	4	23	17.3913043478261	0.00833264328446714	0.0884128604695433	1	1	0.941588691144787	0.953410687097476	0.78332248190033
down	GSTP1; ZFP36; ISL1; SSTR5;	GO:0071385~cellular response to glucocorticoid stimulus	4	23	17.3913043478261	0.00833264328446714	0.0884128604695433	1	1	0.941588691144787	0.953410687097476	0.78332248190033
down	TSPAN6; NLRP12; ADIPOR1; FBXW11;	GO:1901223~negative regulation of NIK/NF-kappaB signaling	4	23	17.3913043478261	0.00833264328446714	0.0884128604695433	1	1	0.941588691144787	0.953410687097476	0.78332248190033
down	WT1; LHX1; FOXC1; SIX1; FOXC2;	GO:0001657~ureteric bud development	5	37	13.5135135135135	0.00838063706485259	0.0884128604695433	1	1	0.942386838990349	0.953410687097476	0.78332248190033
down	MME; ALKBH1; PLAC1; ETNK2; LHX3;	GO:0001890~placenta development	5	37	13.5135135135135	0.00838063706485259	0.0884128604695433	1	1	0.942386838990349	0.953410687097476	0.78332248190033
down	RPA2; RPS3; RBX1; UBA52; UBE2B;	GO:0042769~DNA damage response, detection of DNA damage	5	37	13.5135135135135	0.00838063706485259	0.0884128604695433	1	1	0.942386838990349	0.953410687097476	0.78332248190033
down	EREG; SPRR2B; STK4; ASAH1; PIP5K1A; SPRR2G;	GO:0030216~keratinocyte differentiation	6	53	11.3207547169811	0.00863522624959301	0.0885096146081988	1	1	0.946645412542556	0.953410687097476	0.784179706648214
down	PDCD5; PDCD6; ALOX12; PMAIP1; NDUFA13; FIS1;	GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process	6	53	11.3207547169811	0.00863522624959301	0.0885096146081988	1	1	0.946645412542556	0.953410687097476	0.784179706648214
down	MIF4GD; EIF3D; RPL5; EIF6; EIF3E; RPL26; LARP6;	GO:0045727~positive regulation of translation	7	70	10	0.00864054406645542	0.0885096146081988	1	1	0.946645412542556	0.953410687097476	0.784179706648214
down	POLR2I; POLR2J; POLR2K; POLR2F; POLR2G; GTF2H5; WDR61;	GO:0006368~transcription elongation from RNA polymerase II promoter	7	71	9.85915492957746	0.0092513064626536	0.094047095238889	1	1	0.953410687097476	0.953410687097476	0.833240816627814
down	CCL5; ATF4; CES1; SLC6A1; SCFD1; SLC7A11; PON3;	GO:0009636~response to toxic substance	7	71	9.85915492957746	0.0092513064626536	0.094047095238889	1	1	0.953410687097476	0.953410687097476	0.833240816627814
down	BCL2L1; FOXC1; DMRTA1; ZNF830; EIF2B4;	GO:0001541~ovarian follicle development	5	38	13.1578947368421	0.00925248357307229	0.094047095238889	1	1	0.953410687097476	0.953410687097476	0.833240816627814
down	AR; ADM; ADAMTS16;	GO:0003073~regulation of systemic arterial blood pressure	3	12	25	0.00951005771234725	0.0949564853399521	1	1	0.953410687097476	0.953410687097476	0.841297853886842
down	PGLS; RBKS; DERA;	GO:0006098~pentose-phosphate shunt	3	12	25	0.00951005771234725	0.0949564853399521	1	1	0.953410687097476	0.953410687097476	0.841297853886842
down	CHRNB4; CHRNA3; ATP1A2;	GO:0006940~regulation of smooth muscle contraction	3	12	25	0.00951005771234725	0.0949564853399521	1	1	0.953410687097476	0.953410687097476	0.841297853886842
down	MAPT; PMAIP1; HEBP2;	GO:0010917~negative regulation of mitochondrial membrane potential	3	12	25	0.00951005771234725	0.0949564853399521	1	1	0.953410687097476	0.953410687097476	0.841297853886842
down	CCL5; CXCR2; IL18;	GO:0042119~neutrophil activation	3	12	25	0.00951005771234725	0.0949564853399521	1	1	0.953410687097476	0.953410687097476	0.841297853886842
down	CNOT1; ZFP36; POLR2G;	GO:0060213~positive regulation of nuclear-transcribed mRNA poly(A) tail shortening	3	12	25	0.00951005771234725	0.0949564853399521	1	1	0.953410687097476	0.953410687097476	0.841297853886842
down	MGMT; SPIRE1; SPIDR;	GO:2000781~positive regulation of double-strand break repair	3	12	25	0.00951005771234725	0.0949564853399521	1	1	0.953410687097476	0.953410687097476	0.841297853886842
up	GALR3; EDNRB; CCR2; P2RY13; DRD2;	GO:0007194~negative regulation of adenylate cyclase activity	5	25	20	0.00959187924988836	0.358896148599989	1	1	0.999999965871282	0.999999965871281	1
down	SOX1; PEX7; ASTN1; CDK5R2; ALKBH1; SEMA3A; VAX1; UNK; ELP3;	GO:0001764~neuron migration	9	109	8.25688073394496	0.00966367409269298	0.0960054456344423	1	1	0.953410687097476	0.953410687097476	0.850591458651253
down	ITGB1BP1; RPS19; FOXC1; KAT2B; ITCH; FOXC2; CHAC1; HES7; DLL3;	GO:0007219~Notch signaling pathway	9	109	8.25688073394496	0.00966367409269298	0.0960054456344423	1	1	0.953410687097476	0.953410687097476	0.850591458651253
down	DAPL1; CFAP69; ITGB1BP1; PTPN6; HSD17B7; ATRAID; ATOH7; OSR2; ZIC5; BCL7B; HEMGN; RBM38; YY1AP1; FER; DLX2; LCK; NKX2-8; HES7; SOX1; FOXI3; FOXC1; FGR; FOXC2; NR2E1; FOXD3; PTK6; HCK; DLX6; SRMS;	GO:0030154~cell differentiation	29	572	5.06993006993007	0.00984524209672921	0.0975641284472865	1	1	0.953410687097476	0.953410687097476	0.864401115786745
down	LAMTOR5; DPEP1; MT3; CD27; PRDX5; CSNK2A1; XIAP;	GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	7	72	9.72222222222222	0.00989304970183913	0.0977927963026798	1	1	0.953410687097476	0.953410687097476	0.866427072995529
down	HOXC11; HOXA11; HOXD12; HOXD13; OSR2; ALX4;	GO:0042733~embryonic digit morphogenesis	6	55	10.9090909090909	0.0101173038749475	0.0997601484327738	1	1	0.953410687097476	0.953410687097476	0.883857468812753
down	GSTP1; DUSP1; PTPN6; RGS2; SORL1;	GO:0043407~negative regulation of MAP kinase activity	5	39	12.8205128205128	0.0101848014272159	0.100175882694556	1	1	0.953410687097476	0.953410687097476	0.88754080166751
down	LSM1; BCAS2; SF3B3; SNRNP40;	GO:0000375~RNA splicing, via transesterification reactions	4	25	16	0.0107535070530329	0.104986091080721	1	1	0.953410687097476	0.953410687097476	0.930158406747785
down	EREG; SLC11A1; NFAM1; HILPDA;	GO:0001819~positive regulation of cytokine production	4	25	16	0.0107535070530329	0.104986091080721	1	1	0.953410687097476	0.953410687097476	0.930158406747785
down	NUP214; POLR2I; POLR2J; POLR2K; POLR2F; POLR2G;	GO:0060964~regulation of gene silencing by miRNA	6	56	10.7142857142857	0.0109222917571379	0.106371284748087	1	1	0.953410687097476	0.953410687097476	0.942430980394546
up	SULT1C2; INMT; VCAM1;	GO:0009308~amine metabolic process	3	8	37.5	0.0109550815721888	0.365861099582411	1	1	0.999999965871282	0.999999965871281	1
up	C1QA; C1QB; C1QC;	GO:0098883~synapse pruning	3	8	37.5	0.0109550815721888	0.365861099582411	1	1	0.999999965871282	0.999999965871281	1
up	IDO1; CD40LG; IRF8; SCIMP; CCL19;	GO:0032735~positive regulation of interleukin-12 production	5	26	19.2307692307692	0.0110275857352438	0.365861099582411	1	1	0.999999965871282	0.999999965871281	1
down	ICAM2; FCER1G; PSMC4; PSMD8; PSMC6; SKP1; TAB3; PSMB7; FBXW11;	GO:0002223~stimulatory C-type lectin receptor signaling pathway	9	112	8.03571428571429	0.0112818726514874	0.10826389308908	1	1	0.953410687097476	0.953410687097476	0.959199159311713
down	NIPAL1; NIPA1; NIPA2;	GO:0015693~magnesium ion transport	3	13	23.0769230769231	0.0114451965885775	0.10826389308908	1	1	0.953410687097476	0.953410687097476	0.959199159311713
down	PLEKHF1; SNX11; SAR1A;	GO:0016050~vesicle organization	3	13	23.0769230769231	0.0114451965885775	0.10826389308908	1	1	0.953410687097476	0.953410687097476	0.959199159311713
down	INTS12; INTS7; INTS6;	GO:0016180~snRNA processing	3	13	23.0769230769231	0.0114451965885775	0.10826389308908	1	1	0.953410687097476	0.953410687097476	0.959199159311713
down	SOD2; MPO; MT3;	GO:0019430~removal of superoxide radicals	3	13	23.0769230769231	0.0114451965885775	0.10826389308908	1	1	0.953410687097476	0.953410687097476	0.959199159311713
down	TOX; EOMES; NR2E1;	GO:0021895~cerebral cortex neuron differentiation	3	13	23.0769230769231	0.0114451965885775	0.10826389308908	1	1	0.953410687097476	0.953410687097476	0.959199159311713
down	ATP1A2; PRKCE; C12orf10;	GO:0035641~locomotory exploration behavior	3	13	23.0769230769231	0.0114451965885775	0.10826389308908	1	1	0.953410687097476	0.953410687097476	0.959199159311713
down	CCL5; RGS2; CRY1;	GO:0045744~negative regulation of G protein-coupled receptor signaling pathway	3	13	23.0769230769231	0.0114451965885775	0.10826389308908	1	1	0.953410687097476	0.953410687097476	0.959199159311713
down	LHX1; DLX6; OSR2;	GO:0060322~head development	3	13	23.0769230769231	0.0114451965885775	0.10826389308908	1	1	0.953410687097476	0.953410687097476	0.959199159311713
down	PIAS1; PTPN2; IFNGR2;	GO:0060334~regulation of interferon-gamma-mediated signaling pathway	3	13	23.0769230769231	0.0114451965885775	0.10826389308908	1	1	0.953410687097476	0.953410687097476	0.959199159311713
down	URI1; AR; ATP1A2;	GO:0071383~cellular response to steroid hormone stimulus	3	13	23.0769230769231	0.0114451965885775	0.10826389308908	1	1	0.953410687097476	0.953410687097476	0.959199159311713
down	LEPROT; COMMD1; LEPROTL1;	GO:2000009~negative regulation of protein localization to cell surface	3	13	23.0769230769231	0.0114451965885775	0.10826389308908	1	1	0.953410687097476	0.953410687097476	0.959199159311713
down	TNFAIP8L3; PLPP5; CLN8; GDPD3; PLB1; PLPPR5;	GO:0006644~phospholipid metabolic process	6	57	10.5263157894737	0.0117715296510869	0.109648259741998	1	1	0.953410687097476	0.953410687097476	0.971464405755101
down	OTX1; GBX2; FOXG1; DLX6; SIX1; TMIE;	GO:0042472~inner ear morphogenesis	6	57	10.5263157894737	0.0117715296510869	0.109648259741998	1	1	0.953410687097476	0.953410687097476	0.971464405755101
down	PDCD6; CALM1; ANXA7; DUSP1; SLC6A1; ALG2;	GO:0051592~response to calcium ion	6	57	10.5263157894737	0.0117715296510869	0.109648259741998	1	1	0.953410687097476	0.953410687097476	0.971464405755101
down	DUSP14; DUSP1; DUSP9; DUSP16;	GO:0000188~inactivation of MAPK activity	4	26	15.3846153846154	0.0121170742196408	0.109648259741998	1	1	0.953410687097476	0.953410687097476	0.971464405755101
down	CETN2; RBX1; UBA52; GTF2H5;	GO:0070911~global genome nucleotide-excision repair	4	26	15.3846153846154	0.0121170742196408	0.109648259741998	1	1	0.953410687097476	0.953410687097476	0.971464405755101
down	AHRR; CYP26A1; AKR7A2; GSTP1; DPEP1; CES1; S100A12; GUK1;	GO:0006805~xenobiotic metabolic process	8	94	8.51063829787234	0.0122021654423358	0.109648259741998	1	1	0.953410687097476	0.953410687097476	0.971464405755101
up	TRPM2; CCR2; CCR5; CCL19;	GO:0002407~dendritic cell chemotaxis	4	17	23.5294117647059	0.0125536146935663	0.398505825591786	1	1	0.999999965871282	0.999999965871281	1
up	AIF1; CCL19; RARRES2; P2RY12;	GO:0050921~positive regulation of chemotaxis	4	17	23.5294117647059	0.0125536146935663	0.398505825591786	1	1	0.999999965871282	0.999999965871281	1
up	C1QA; IL13; AIF1; TLR8; TLR7;	GO:0001774~microglial cell activation	5	27	18.5185185185185	0.0126030795621456	0.398505825591786	1	1	0.999999965871282	0.999999965871281	1
down	PSMC4; PSMD8; PSMC6; RBX1; SKP1; PSMB7; FBXW11; FBXL16;	GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process	8	95	8.42105263157895	0.0128899758356719	0.11201530649285	1	1	0.953410687097476	0.953410687097476	0.992436026012656
down	CA1; SLC4A1; HBB; CYB5RL; SLC26A10;	GO:0015701~bicarbonate transport	5	42	11.9047619047619	0.0133630347853284	0.11327150185391	1	1	0.953410687097476	0.953410687097476	1
down	ITGB2; CXCR2; FCER1G; GRK4; ADM;	GO:0031623~receptor internalization	5	42	11.9047619047619	0.0133630347853284	0.11327150185391	1	1	0.953410687097476	0.953410687097476	1
down	PFKFB2; RBP4; ISL1; PRKCE; IRS2;	GO:0032024~positive regulation of insulin secretion	5	42	11.9047619047619	0.0133630347853284	0.11327150185391	1	1	0.953410687097476	0.953410687097476	1
down	ITGB1BP1; CCL5; ZFP36; LHX1;	GO:0044344~cellular response to fibroblast growth factor stimulus	4	27	14.8148148148148	0.0135865072047826	0.11327150185391	1	1	0.953410687097476	0.953410687097476	1
down	LCK; HCK; CD247; AP2S1;	GO:0050690~regulation of defense response to virus by virus	4	27	14.8148148148148	0.0135865072047826	0.11327150185391	1	1	0.953410687097476	0.953410687097476	1
down	ZFAND5; FLT4; TCF15;	GO:0003016~respiratory system process	3	14	21.4285714285714	0.0135901393118245	0.11327150185391	1	1	0.953410687097476	0.953410687097476	1
down	HBD; MB; HBB;	GO:0015671~oxygen transport	3	14	21.4285714285714	0.0135901393118245	0.11327150185391	1	1	0.953410687097476	0.953410687097476	1
down	NCAN; CSPG5; IDS;	GO:0030207~chondroitin sulfate catabolic process	3	14	21.4285714285714	0.0135901393118245	0.11327150185391	1	1	0.953410687097476	0.953410687097476	1
down	MEFV; GSTP1; CX3CR1;	GO:0032691~negative regulation of interleukin-1 beta production	3	14	21.4285714285714	0.0135901393118245	0.11327150185391	1	1	0.953410687097476	0.953410687097476	1
down	PTPN2; FOXO1; KAT2B;	GO:0045722~positive regulation of gluconeogenesis	3	14	21.4285714285714	0.0135901393118245	0.11327150185391	1	1	0.953410687097476	0.953410687097476	1
down	WNT10B; SCNN1B; CALHM3;	GO:0050909~sensory perception of taste	3	14	21.4285714285714	0.0135901393118245	0.11327150185391	1	1	0.953410687097476	0.953410687097476	1
down	PTPN2; RACK1; PTK6;	GO:0061099~negative regulation of protein tyrosine kinase activity	3	14	21.4285714285714	0.0135901393118245	0.11327150185391	1	1	0.953410687097476	0.953410687097476	1
down	ATP1A2; SCNN1B; SLC5A12; SLC34A3; SLC38A3; SLC38A1; SCN3B;	GO:0006814~sodium ion transport	7	77	9.09090909090909	0.013596342353245	0.11327150185391	1	1	0.953410687097476	0.953410687097476	1
down	AGTR1; ARHGDIB; RHOD; CDC42EP3; C15orf62; RND3; CDC42;	GO:0007266~Rho protein signal transduction	7	77	9.09090909090909	0.013596342353245	0.11327150185391	1	1	0.953410687097476	0.953410687097476	1
down	ITGB1BP1; DKK1; SLPI; RACK1; PIN1; SORL1; SENP2;	GO:0032091~negative regulation of protein binding	7	77	9.09090909090909	0.013596342353245	0.11327150185391	1	1	0.953410687097476	0.953410687097476	1
down	GSTZ1; HBD; GSTP1; ALOX5AP; PRDX6; PRDX5; HBB;	GO:0098869~cellular oxidant detoxification	7	77	9.09090909090909	0.013596342353245	0.11327150185391	1	1	0.953410687097476	0.953410687097476	1
down	CHRNB4; CHRNA3; GLRB; MLC1; FXN; SLC5A12; SLC20A1; FXYD5;	GO:0006811~ion transport	8	96	8.33333333333333	0.0136057292153307	0.11327150185391	1	1	0.953410687097476	0.953410687097476	1
down	ITGB1BP1; ADAM11; ITGB2; HCK; FGR; FCER1G; CDC42; FERMT3;	GO:0007229~integrin-mediated signaling pathway	8	96	8.33333333333333	0.0136057292153307	0.11327150185391	1	1	0.953410687097476	0.953410687097476	1
down	LSM1; DDX6; FOXG1; ISL1; ISL2; NR2E1;	GO:0045665~negative regulation of neuron differentiation	6	59	10.1694915254237	0.0136074768286817	0.11327150185391	1	1	0.953410687097476	0.953410687097476	1
down	ATP6V0E1; ATP6V1G1; COX5A; UCP2; ATP6V1F; ATP6V1E2; NOX5; NDUFA4L2; ATP1A2;	GO:1902600~proton transmembrane transport	9	116	7.75862068965517	0.0137443561481509	0.114170555062582	1	1	0.953410687097476	0.953410687097476	1
up	LY86; SCIMP; CD180;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	3	9	33.3333333333333	0.0141311512844531	0.44061714768885	1	1	0.999999965871282	0.999999965871281	1
down	GABRD; BEST1; SLC4A1; GLRB; CLDN17; SLC26A10; CLCA3P; GABRA3;	GO:1902476~chloride transmembrane transport	8	97	8.24742268041237	0.0143500385708722	0.118703038722236	1	1	0.953410687097476	0.953410687097476	1
down	RHOD; RPL11; SORL1; HPS4; HOMER3;	GO:0006605~protein targeting	5	43	11.6279069767442	0.0145553788890889	0.119491728969256	1	1	0.953410687097476	0.953410687097476	1
down	CALM1; CASP5; CDC42; BASP1; PADI2;	GO:0021762~substantia nigra development	5	43	11.6279069767442	0.0145553788890889	0.119491728969256	1	1	0.953410687097476	0.953410687097476	1
down	MAPT; PLK3; STMN3; CAMSAP2; TUBGCP5;	GO:0031122~cytoplasmic microtubule organization	5	43	11.6279069767442	0.0145553788890889	0.119491728969256	1	1	0.953410687097476	0.953410687097476	1
down	ALPL; ANXA3; AREG; IL1RN; DUSP1; ADM;	GO:0051384~response to glucocorticoid	6	60	10	0.0145964858604326	0.119491728969256	1	1	0.953410687097476	0.953410687097476	1
down	TH; GATA4; RACK1; FIS1; IRS2; PCK2;	GO:0071333~cellular response to glucose stimulus	6	60	10	0.0145964858604326	0.119491728969256	1	1	0.953410687097476	0.953410687097476	1
down	MAPT; FER; CAMSAP2; UXT; TUBB1; TUBB4A; PPP2R3C; CALM1; MARK3;	GO:0000226~microtubule cytoskeleton organization	9	118	7.6271186440678	0.0151149121975306	0.122367174369897	1	1	0.953410687097476	0.953410687097476	1
down	RPS19; GTF2H5; RPS8; RPS14;	GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)	4	28	14.2857142857143	0.0151643691050201	0.122367174369897	1	1	0.953410687097476	0.953410687097476	1
down	QRFP; ADRB1; ADRA1B; ADRA2C;	GO:0007610~behavior	4	28	14.2857142857143	0.0151643691050201	0.122367174369897	1	1	0.953410687097476	0.953410687097476	1
down	MSX1; WNT3; OSR2; ALX4;	GO:0035116~embryonic hindlimb morphogenesis	4	28	14.2857142857143	0.0151643691050201	0.122367174369897	1	1	0.953410687097476	0.953410687097476	1
down	OPRD1; BCL2L1; SLC25A33; PANK2;	GO:0051881~regulation of mitochondrial membrane potential	4	28	14.2857142857143	0.0151643691050201	0.122367174369897	1	1	0.953410687097476	0.953410687097476	1
down	ATP6V0E1; ATP6V1G1; ATP6V1F; ATP6V1E2;	GO:0090383~phagosome acidification	4	28	14.2857142857143	0.0151643691050201	0.122367174369897	1	1	0.953410687097476	0.953410687097476	1
down	CTH; GATA4; CX3CR1; CSNK2A1;	GO:2001234~negative regulation of apoptotic signaling pathway	4	28	14.2857142857143	0.0151643691050201	0.122367174369897	1	1	0.953410687097476	0.953410687097476	1
down	FGF19; FGF5; POLR2I; POLR2J; POLR2K; POLR2F; POLR2G;	GO:0008543~fibroblast growth factor receptor signaling pathway	7	79	8.86075949367089	0.015324025349291	0.123403658311806	1	1	0.953410687097476	0.953410687097476	1
down	DKK1; SNAPIN; MT3; STX1B; SEMA3A; DGUOK;	GO:0010977~negative regulation of neuron projection development	6	61	9.83606557377049	0.0156343408616185	0.124866684045327	1	1	0.953410687097476	0.953410687097476	1
down	SPTA1; CD3E; CCL5; ZP3; IL12A; CD6;	GO:0042102~positive regulation of T cell proliferation	6	61	9.83606557377049	0.0156343408616185	0.124866684045327	1	1	0.953410687097476	0.953410687097476	1
down	ARIH2; UBE2B; ITCH; UBE2E2; HECTD1;	GO:0070534~protein K63-linked ubiquitination	5	44	11.3636363636364	0.0158169426633611	0.124866684045327	1	1	0.953410687097476	0.953410687097476	1
down	HYKK; ADK; PMVK; IDNK; SEPHS2; PANK2; ETNK2; DOLK;	GO:0016310~phosphorylation	8	99	8.08080808080808	0.015926748108458	0.124866684045327	1	1	0.953410687097476	0.953410687097476	1
down	ADM; TIPARP; HSD17B8;	GO:0008209~androgen metabolic process	3	15	20	0.0159478187766541	0.124866684045327	1	1	0.953410687097476	0.953410687097476	1
down	ALOX12; ADIPOR2; ADIPOR1;	GO:0019395~fatty acid oxidation	3	15	20	0.0159478187766541	0.124866684045327	1	1	0.953410687097476	0.953410687097476	1
down	EPB41L3; PPP2R3C; CDC42;	GO:0030865~cortical cytoskeleton organization	3	15	20	0.0159478187766541	0.124866684045327	1	1	0.953410687097476	0.953410687097476	1
down	KAT5; HOMER2; HOMER3;	GO:0032703~negative regulation of interleukin-2 production	3	15	20	0.0159478187766541	0.124866684045327	1	1	0.953410687097476	0.953410687097476	1
down	ACOT8; ACOX2; ACOXL;	GO:0033540~fatty acid beta-oxidation using acyl-CoA oxidase	3	15	20	0.0159478187766541	0.124866684045327	1	1	0.953410687097476	0.953410687097476	1
down	TOR1A; SNAPIN; TMEM230;	GO:0048489~synaptic vesicle transport	3	15	20	0.0159478187766541	0.124866684045327	1	1	0.953410687097476	0.953410687097476	1
down	LCK; RPS3; CCR7;	GO:0050862~positive regulation of T cell receptor signaling pathway	3	15	20	0.0159478187766541	0.124866684045327	1	1	0.953410687097476	0.953410687097476	1
down	TBC1D10C; HOMER2; HOMER3;	GO:0070885~negative regulation of calcineurin-NFAT signaling cascade	3	15	20	0.0159478187766541	0.124866684045327	1	1	0.953410687097476	0.953410687097476	1
down	CNOT1; ZFP36; NANOS1;	GO:1900153~positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay	3	15	20	0.0159478187766541	0.124866684045327	1	1	0.953410687097476	0.953410687097476	1
down	NIPAL1; NIPA1; NIPA2;	GO:1903830~magnesium ion transmembrane transport	3	15	20	0.0159478187766541	0.124866684045327	1	1	0.953410687097476	0.953410687097476	1
up	TRPA1; CCL2; ADCYAP1; EDNRB; CNR2; CCR2; POMK;	GO:0019233~sensory perception of pain	7	53	13.2075471698113	0.0164889062447655	0.460975763402548	1	1	0.999999965871282	0.999999965871281	1
up	CTLA4; DPP4; CD40LG; CD80; CCL19; PDCD1LG2; ICOS;	GO:0031295~T cell costimulation	7	53	13.2075471698113	0.0164889062447655	0.460975763402548	1	1	0.999999965871282	0.999999965871281	1
down	RPLP1; RPS14; RPL38; MAPKAPK5; EIF2B4; CYFIP1;	GO:0006417~regulation of translation	6	62	9.67741935483871	0.0167221229517074	0.126259331273901	1	1	0.953410687097476	0.953410687097476	1
down	PTH1R; ADRB1; ADRA2C; GNAZ; GNAQ; ADRA1B;	GO:0007188~adenylate cyclase-modulating G protein-coupled receptor signaling pathway	6	62	9.67741935483871	0.0167221229517074	0.126259331273901	1	1	0.953410687097476	0.953410687097476	1
down	TH; FOSL1; COMT; SLC6A1; NTSR1; JPH3;	GO:0007612~learning	6	62	9.67741935483871	0.0167221229517074	0.126259331273901	1	1	0.953410687097476	0.953410687097476	1
down	PIAS1; RPA2; CACUL1; CRLF3; PLK3; POLE4; PLK2; GPR132;	GO:0000082~G1/S transition of mitotic cell cycle	8	100	8	0.016760343395823	0.126259331273901	1	1	0.953410687097476	0.953410687097476	1
down	CCL5; IFNL1; CRLF3; ADIPOR1;	GO:0046427~positive regulation of receptor signaling pathway via JAK-STAT	4	29	13.7931034482759	0.0168530060888963	0.126259331273901	1	1	0.953410687097476	0.953410687097476	1
down	UBE2B; UBE2E2; ANAPC11; ANAPC7;	GO:0070979~protein K11-linked ubiquitination	4	29	13.7931034482759	0.0168530060888963	0.126259331273901	1	1	0.953410687097476	0.953410687097476	1
down	FPR2; SLC11A1; TUB; FCER1G; SIRPB1;	GO:0050766~positive regulation of phagocytosis	5	45	11.1111111111111	0.017149272030147	0.126259331273901	1	1	0.953410687097476	0.953410687097476	1
up	CCL2; CD40LG; FASLG; ECSCR;	GO:2000353~positive regulation of endothelial cell apoptotic process	4	19	21.0526315789474	0.0173182683811359	0.460975763402548	1	1	0.999999965871282	0.999999965871281	1
down	CPSF4; NUP214; SRSF5; THOC7; FIP1L1; FYTTD1; NXT1; CHTOP;	GO:0006406~mRNA export from nucleus	8	101	7.92079207920792	0.0176248836784819	0.128577103440438	1	1	0.953410687097476	0.953410687097476	1
up	IL18RAP; AVPR2; LILRB1;	GO:0032609~interferon-gamma production	3	10	30	0.0177737898145418	0.460975763402548	1	1	0.999999965871282	0.999999965871281	1
down	PSMC4; PSMD8; PSMC6; SKP1; PSMB7; FBXW11;	GO:0038061~NIK/NF-kappaB signaling	6	63	9.52380952380952	0.0178608828360591	0.130058804297933	1	1	0.953410687097476	0.953410687097476	1
down	DPEP1; ALOX5AP; LCE1D; RASGRP2; SYT3; SYT7; CPNE4;	GO:0071277~cellular response to calcium ion	7	82	8.53658536585366	0.0181995908525004	0.130548811051579	1	1	0.953410687097476	0.953410687097476	1
up	TYROBP; DRD2; GIPR; AIF1; P2RY12;	GO:0048678~response to axon injury	5	30	16.6666666666667	0.0182230763477834	0.460975763402548	1	1	0.999999965871282	0.999999965871281	1
up	CCL2; PCK1; PTGIS; XCL2; CCL13; CCL14; CCL11; CCL18; CCL19;	GO:0071347~cellular response to interleukin-1	9	81	11.1111111111111	0.0182747630034863	0.460975763402548	1	1	0.999999965871282	0.999999965871281	1
down	LHX1; WNT3; RNF2;	GO:0009948~anterior/posterior axis specification	3	16	18.75	0.0185202778035218	0.130548811051579	1	1	0.953410687097476	0.953410687097476	1
down	OXSR1; CCL5; STK39;	GO:0010820~positive regulation of T cell chemotaxis	3	16	18.75	0.0185202778035218	0.130548811051579	1	1	0.953410687097476	0.953410687097476	1
down	DEDD2; EXOSC7; EXOSC6;	GO:0016075~rRNA catabolic process	3	16	18.75	0.0185202778035218	0.130548811051579	1	1	0.953410687097476	0.953410687097476	1
down	EDN2; AGTR1; ATP1A2;	GO:0019229~regulation of vasoconstriction	3	16	18.75	0.0185202778035218	0.130548811051579	1	1	0.953410687097476	0.953410687097476	1
down	ALOX12; ALOX5AP; PON3;	GO:0019372~lipoxygenase pathway	3	16	18.75	0.0185202778035218	0.130548811051579	1	1	0.953410687097476	0.953410687097476	1
down	NCF1; ALOX12; NOX5;	GO:0042554~superoxide anion generation	3	16	18.75	0.0185202778035218	0.130548811051579	1	1	0.953410687097476	0.953410687097476	1
down	PPP1R3G; IGF2; IRS2;	GO:0045725~positive regulation of glycogen biosynthetic process	3	16	18.75	0.0185202778035218	0.130548811051579	1	1	0.953410687097476	0.953410687097476	1
down	ISL1; SIX1; ISL2;	GO:0048665~neuron fate specification	3	16	18.75	0.0185202778035218	0.130548811051579	1	1	0.953410687097476	0.953410687097476	1
down	CAMSAP2; KNDC1; CSMD3;	GO:0050773~regulation of dendrite development	3	16	18.75	0.0185202778035218	0.130548811051579	1	1	0.953410687097476	0.953410687097476	1
down	SLC6A2; TYRO3; FGGY;	GO:0070050~neuron cellular homeostasis	3	16	18.75	0.0185202778035218	0.130548811051579	1	1	0.953410687097476	0.953410687097476	1
down	DPEP1; MT3; FOXO1;	GO:0071732~cellular response to nitric oxide	3	16	18.75	0.0185202778035218	0.130548811051579	1	1	0.953410687097476	0.953410687097476	1
down	CHRNA3; RIMS4; POPDC3; GABRA3; KCNH3; GABRD; GLRB; CHRNB4;	GO:0042391~regulation of membrane potential	8	102	7.84313725490196	0.0185209475049861	0.130548811051579	1	1	0.953410687097476	0.953410687097476	1
down	TCF15; FOXC1; FOXC2; HES7; DLL3;	GO:0001756~somitogenesis	5	46	10.8695652173913	0.0185538387758333	0.130548811051579	1	1	0.953410687097476	0.953410687097476	1
down	ANXA7; COMT; CD83; NEDD8; SLC7A11;	GO:0014070~response to organic cyclic compound	5	46	10.8695652173913	0.0185538387758333	0.130548811051579	1	1	0.953410687097476	0.953410687097476	1
down	PTPN2; ALAS2; RPS19; RPS14; TMEM14C;	GO:0030218~erythrocyte differentiation	5	46	10.8695652173913	0.0185538387758333	0.130548811051579	1	1	0.953410687097476	0.953410687097476	1
down	CYP26A1; DKK1; RBP4; DUSP1; TRIML2;	GO:0032526~response to retinoic acid	5	46	10.8695652173913	0.0185538387758333	0.130548811051579	1	1	0.953410687097476	0.953410687097476	1
down	EDF1; ISL1; FOXC1; PYHIN1;	GO:0043388~positive regulation of DNA binding	4	30	13.3333333333333	0.0186545468498083	0.130548811051579	1	1	0.953410687097476	0.953410687097476	1
down	MB; ADRB1; RGS2; METRNL;	GO:0050873~brown fat cell differentiation	4	30	13.3333333333333	0.0186545468498083	0.130548811051579	1	1	0.953410687097476	0.953410687097476	1
down	CCR7; CDC42; PLPPR5; MIEN1;	GO:0051491~positive regulation of filopodium assembly	4	30	13.3333333333333	0.0186545468498083	0.130548811051579	1	1	0.953410687097476	0.953410687097476	1
down	MSX1; MMP13; OSR2; PAPPA2;	GO:0060349~bone morphogenesis	4	30	13.3333333333333	0.0186545468498083	0.130548811051579	1	1	0.953410687097476	0.953410687097476	1
down	TOR1A; PEX19; CSNK2A1; ST13;	GO:0061077~chaperone-mediated protein folding	4	30	13.3333333333333	0.0186545468498083	0.130548811051579	1	1	0.953410687097476	0.953410687097476	1
down	UBA52; LAMTOR1; CHMP4C; UBAP1; MYO5B; BLOC1S2; BLOC1S1;	GO:0016197~endosomal transport	7	83	8.43373493975904	0.0192369206241174	0.133913352372817	1	1	0.953410687097476	0.953410687097476	1
down	EREG; HDAC3; DEAF1; WT1; ZP3; MT3; LHX1; FOXG1; BASP1; FOXO1; FOXF2; CRY1; LRRFIP1; COMMD7; IFNL1; DMBX1; DEDD2; KAT5; MTERF3; TRIB3; PFDN5; THAP7; HMX1; NDUFA13; FBXW11; SIX1;	GO:0045892~negative regulation of transcription, DNA-templated	26	530	4.90566037735849	0.0198011052543049	0.137598541609001	1	1	0.953410687097476	0.953410687097476	1
down	EREG; TH; AREG; EIF2B3; EIF2B4;	GO:0043434~response to peptide hormone	5	47	10.6382978723404	0.0200320384178654	0.13871572662739	1	1	0.953410687097476	0.953410687097476	1
down	WNT10B; ATF4; RHEB; FOXC2; HOXC10;	GO:0120163~negative regulation of cold-induced thermogenesis	5	47	10.6382978723404	0.0200320384178654	0.13871572662739	1	1	0.953410687097476	0.953410687097476	1
down	NDUFS6; AR; EN1; SLC25A25; APBA2; ETNK2; CELA1;	GO:0035264~multicellular organism growth	7	84	8.33333333333333	0.0203148849282876	0.140428417843443	1	1	0.953410687097476	0.953410687097476	1
down	MFNG; HOXD12; LHX1; SIX1;	GO:0007389~pattern specification process	4	31	12.9032258064516	0.0205709029380592	0.14096594491696	1	1	0.953410687097476	0.953410687097476	1
down	S100A8; TH; CRIP1; SLC30A3;	GO:0010043~response to zinc ion	4	31	12.9032258064516	0.0205709029380592	0.14096594491696	1	1	0.953410687097476	0.953410687097476	1
down	FGR; CCR7; CDC42; TNFAIP8L3;	GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity	4	31	12.9032258064516	0.0205709029380592	0.14096594491696	1	1	0.953410687097476	0.953410687097476	1
down	CERS1; ASAH1; CYP4F22; CLN8;	GO:0046513~ceramide biosynthetic process	4	31	12.9032258064516	0.0205709029380592	0.14096594491696	1	1	0.953410687097476	0.953410687097476	1
down	S100A8; DYNLT1; TJP1; STMN3;	GO:0051493~regulation of cytoskeleton organization	4	31	12.9032258064516	0.0205709029380592	0.14096594491696	1	1	0.953410687097476	0.953410687097476	1
down	CCL5; CXCR2; CCR7;	GO:0002407~dendritic cell chemotaxis	3	17	17.6470588235294	0.021308735837213	0.14345956042733	1	1	0.953410687097476	0.953410687097476	1
down	PHGDH; GFPT2; NIT2;	GO:0006541~glutamine metabolic process	3	17	17.6470588235294	0.021308735837213	0.14345956042733	1	1	0.953410687097476	0.953410687097476	1
down	ACYP2; SLC20A1; LHPP;	GO:0006796~phosphate-containing compound metabolic process	3	17	17.6470588235294	0.021308735837213	0.14345956042733	1	1	0.953410687097476	0.953410687097476	1
down	PRKCH; AGTR1; IL18;	GO:0010744~positive regulation of macrophage derived foam cell differentiation	3	17	17.6470588235294	0.021308735837213	0.14345956042733	1	1	0.953410687097476	0.953410687097476	1
down	MTERF4; METTL5; TRMT112;	GO:0031167~rRNA methylation	3	17	17.6470588235294	0.021308735837213	0.14345956042733	1	1	0.953410687097476	0.953410687097476	1
down	TOX; LTA; LTB;	GO:0048535~lymph node development	3	17	17.6470588235294	0.021308735837213	0.14345956042733	1	1	0.953410687097476	0.953410687097476	1
down	ITGB2; CES1; FCER1G;	GO:0071404~cellular response to low-density lipoprotein particle stimulus	3	17	17.6470588235294	0.021308735837213	0.14345956042733	1	1	0.953410687097476	0.953410687097476	1
down	PIM1; SIX1; METRNL;	GO:0090336~positive regulation of brown fat cell differentiation	3	17	17.6470588235294	0.021308735837213	0.14345956042733	1	1	0.953410687097476	0.953410687097476	1
down	PTPN6; SENP2; TMEM14B;	GO:2000045~regulation of G1/S transition of mitotic cell cycle	3	17	17.6470588235294	0.021308735837213	0.14345956042733	1	1	0.953410687097476	0.953410687097476	1
down	EDN2; FPR2; AGTR1; CXCR2; CALM1; CX3CR1; CCR7;	GO:0019722~calcium-mediated signaling	7	85	8.23529411764706	0.0214341963737988	0.14345956042733	1	1	0.953410687097476	0.953410687097476	1
down	OXSR1; CSNK2B; CSNK2A1; HIPK3; STK39; CSNK2A3;	GO:0018107~peptidyl-threonine phosphorylation	6	66	9.09090909090909	0.0215930493311998	0.14345956042733	1	1	0.953410687097476	0.953410687097476	1
down	FOSL1; ADRA2C; ENDOU; COMT; ADM; ADIPOR2; SLC38A3;	GO:0007565~female pregnancy	7	86	8.13953488372093	0.022595549257867	0.14345956042733	1	1	0.953410687097476	0.953410687097476	1
down	SLC6A1; SLC6A2; SLC6A11; UNC50;	GO:0006810~transport	4	32	12.5	0.022603769890295	0.14345956042733	1	1	0.953410687097476	0.953410687097476	1
down	AQP9; SCNN1B; UGT1A7; GRHPR;	GO:0007588~excretion	4	32	12.5	0.022603769890295	0.14345956042733	1	1	0.953410687097476	0.953410687097476	1
down	ITGB1BP1; ADRA2C; MT3; IL18;	GO:0032148~activation of protein kinase B activity	4	32	12.5	0.022603769890295	0.14345956042733	1	1	0.953410687097476	0.953410687097476	1
down	TOR1A; TOR1B; HSPA6; ST13;	GO:0051085~chaperone cofactor-dependent protein refolding	4	32	12.5	0.022603769890295	0.14345956042733	1	1	0.953410687097476	0.953410687097476	1
down	DKK1; KAT2B; SLC7A11; MED31;	GO:0060173~limb development	4	32	12.5	0.022603769890295	0.14345956042733	1	1	0.953410687097476	0.953410687097476	1
up	TRPA1; AMPD1; CTSC; HPR; HP;	GO:0010033~response to organic substance	5	32	15.625	0.0227631773846901	0.541129402107392	1	1	0.999999965871282	0.999999965871281	1
down	PRDM1; LHX1; TIPARP; ALX4; ETNK2; CELA1;	GO:0009791~post-embryonic development	6	67	8.95522388059701	0.0229455686488665	0.145395478265414	1	1	0.953410687097476	0.953410687097476	1
up	CYP2C9; CYP2C19; CYP4A11; CYP2F1;	GO:0019373~epoxygenase P450 pathway	4	21	19.047619047619	0.0230742867674065	0.541129402107392	1	1	0.999999965871282	0.999999965871281	1
down	HAX1; FGR; CCL5; NCF1; PTPN6; IL18; IRS2;	GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling	7	87	8.04597701149425	0.0237996187840012	0.150565908275105	1	1	0.953410687097476	0.953410687097476	1
down	MFNG; ZP3; SF3B6;	GO:0001825~blastocyst formation	3	18	16.6666666666667	0.0243136519627483	0.152597110890011	1	1	0.953410687097476	0.953410687097476	1
down	MTX2; APOO; TMEM11;	GO:0007007~inner mitochondrial membrane organization	3	18	16.6666666666667	0.0243136519627483	0.152597110890011	1	1	0.953410687097476	0.953410687097476	1
down	ASGR1; FOSL1; CDKN2B;	GO:0031668~cellular response to extracellular stimulus	3	18	16.6666666666667	0.0243136519627483	0.152597110890011	1	1	0.953410687097476	0.953410687097476	1
down	ITGB2; CD14; S100A14;	GO:0034142~toll-like receptor 4 signaling pathway	3	18	16.6666666666667	0.0243136519627483	0.152597110890011	1	1	0.953410687097476	0.953410687097476	1
down	SNAPIN; SORL1; ISCA2;	GO:0051604~protein maturation	3	18	16.6666666666667	0.0243136519627483	0.152597110890011	1	1	0.953410687097476	0.953410687097476	1
down	SYT7; CCL5; ADRA2C; UQCC2; ARL2BP; SSTR5;	GO:0050796~regulation of insulin secretion	6	68	8.82352941176471	0.0243538137093995	0.152606940423083	1	1	0.953410687097476	0.953410687097476	1
down	BCDIN3D; TRMT12; LCMT2; TRMT112;	GO:0030488~tRNA methylation	4	33	12.1212121212121	0.0247546290807339	0.154628441366859	1	1	0.953410687097476	0.953410687097476	1
down	ATP1A2; GUK1; SLC25A25; OLA1;	GO:0046034~ATP metabolic process	4	33	12.1212121212121	0.0247546290807339	0.154628441366859	1	1	0.953410687097476	0.953410687097476	1
down	MFNG; ITGB1BP1; KAT2B; SLC35C2; BMP2K;	GO:0045747~positive regulation of Notch signaling pathway	5	50	10	0.0249212081730976	0.155178672624296	1	1	0.953410687097476	0.953410687097476	1
down	NMT2; NUP214; KPNA1; UBA52; UBAP1;	GO:0075733~intracellular transport of virus	5	50	10	0.0249212081730976	0.155178672624296	1	1	0.953410687097476	0.953410687097476	1
down	FZD7; PSMC4; PSMD8; AP2S1; CDC42; PSMC6; PSMB7;	GO:0060071~Wnt signaling pathway, planar cell polarity pathway	7	88	7.95454545454545	0.025047060308198	0.155717101350024	1	1	0.953410687097476	0.953410687097476	1
up	ABRA; GPR174; GPR65; F2RL3; P2RY10;	GO:0035025~positive regulation of Rho protein signal transduction	5	33	15.1515151515152	0.0252839921867934	0.541129402107392	1	1	0.999999965871282	0.999999965871281	1
down	IGF2; AR; TIMP2; ADRA2C; ADRA1B; FLT4; PRKCE; LAMTOR1;	GO:0043410~positive regulation of MAPK cascade	8	109	7.3394495412844	0.0257226993032399	0.15966648829672	1	1	0.953410687097476	0.953410687097476	1
down	UBE2B; NFX1; RNF10; TRIM58; ITCH; RNF181;	GO:0051865~protein autoubiquitination	6	69	8.69565217391304	0.0258186242695969	0.159760313555534	1	1	0.953410687097476	0.953410687097476	1
down	WNT10B; FZD7; ABL2; WNT3; PTK6; NDUFA13;	GO:0071300~cellular response to retinoic acid	6	69	8.69565217391304	0.0258186242695969	0.159760313555534	1	1	0.953410687097476	0.953410687097476	1
up	CTSG; CPA3; CMA1;	GO:0002003~angiotensin maturation	3	12	25	0.0264760103966126	0.541129402107392	1	1	0.999999965871282	0.999999965871281	1
up	ADH1B; ADH1C; ADH1A;	GO:0006069~ethanol oxidation	3	12	25	0.0264760103966126	0.541129402107392	1	1	0.999999965871282	0.999999965871281	1
up	IL10; SLAMF1; TIGIT;	GO:0032695~negative regulation of interleukin-12 production	3	12	25	0.0264760103966126	0.541129402107392	1	1	0.999999965871282	0.999999965871281	1
up	IL2RA; CTLA4; FCGR2B;	GO:0050777~negative regulation of immune response	3	12	25	0.0264760103966126	0.541129402107392	1	1	0.999999965871282	0.999999965871281	1
up	TRPM2; FLT3; LILRB1;	GO:0097028~dendritic cell differentiation	3	12	25	0.0264760103966126	0.541129402107392	1	1	0.999999965871282	0.999999965871281	1
up	GALR3; S100B; CHRNA7; GLP1R; CCL11; LILRB2; POMK;	GO:0007611~learning or memory	7	59	11.864406779661	0.0265141355152843	0.541129402107392	1	1	0.999999965871282	0.999999965871281	1
down	WNT10B; LAMTOR5; PPP1R15A; IL12A; CDKN2B; MLF1; RHEB; LAMTOR1; KAT2B;	GO:0007050~cell cycle arrest	9	131	6.87022900763359	0.0265728141644506	0.161384308712801	1	1	0.953410687097476	0.953410687097476	1
down	PSMC4; PSMD8; PSMC6; PSMB7; OAZ3;	GO:0006521~regulation of cellular amino acid metabolic process	5	51	9.80392156862745	0.026706308660684	0.161384308712801	1	1	0.953410687097476	0.953410687097476	1
down	CD14; MIF; FCER1G; ISL1; ARHGEF2;	GO:0032760~positive regulation of tumor necrosis factor production	5	51	9.80392156862745	0.026706308660684	0.161384308712801	1	1	0.953410687097476	0.953410687097476	1
up	ADRA2A; AIF1; ROBO2; AVPR2; RAMP3; AVPR1A;	GO:0032870~cellular response to hormone stimulus	6	46	13.0434782608696	0.0268316082628774	0.542675320271711	1	1	0.999999965871282	0.999999965871281	1
down	PSMC4; DAD1; EMG1;	GO:0001824~blastocyst development	3	19	15.7894736842105	0.0275347844135994	0.161384308712801	1	1	0.953410687097476	0.953410687097476	1
down	AQP9; TSC22D3; PLK3;	GO:0006970~response to osmotic stress	3	19	15.7894736842105	0.0275347844135994	0.161384308712801	1	1	0.953410687097476	0.953410687097476	1
down	DLX2; OSR2; DLX6;	GO:0009790~embryo development	3	19	15.7894736842105	0.0275347844135994	0.161384308712801	1	1	0.953410687097476	0.953410687097476	1
down	MYO5B; MYO1F; MYO1H;	GO:0030050~vesicle transport along actin filament	3	19	15.7894736842105	0.0275347844135994	0.161384308712801	1	1	0.953410687097476	0.953410687097476	1
down	TOMM7; GRPEL2; TIMM17B;	GO:0030150~protein import into mitochondrial matrix	3	19	15.7894736842105	0.0275347844135994	0.161384308712801	1	1	0.953410687097476	0.953410687097476	1
down	WT1; HOXD13; GREB1L;	GO:0030539~male genitalia development	3	19	15.7894736842105	0.0275347844135994	0.161384308712801	1	1	0.953410687097476	0.953410687097476	1
down	CST7; TNFRSF1B; RNF10;	GO:0031643~positive regulation of myelination	3	19	15.7894736842105	0.0275347844135994	0.161384308712801	1	1	0.953410687097476	0.953410687097476	1
down	FGR; CSNK2B; ELP3;	GO:0045859~regulation of protein kinase activity	3	19	15.7894736842105	0.0275347844135994	0.161384308712801	1	1	0.953410687097476	0.953410687097476	1
down	MTHFD2; ALDH1L2; MTRR;	GO:0046655~folic acid metabolic process	3	19	15.7894736842105	0.0275347844135994	0.161384308712801	1	1	0.953410687097476	0.953410687097476	1
down	ITGB2; PRKCE; BST1;	GO:0050730~regulation of peptidyl-tyrosine phosphorylation	3	19	15.7894736842105	0.0275347844135994	0.161384308712801	1	1	0.953410687097476	0.953410687097476	1
down	HAX1; HCK; CDC42;	GO:2000251~positive regulation of actin cytoskeleton reorganization	3	19	15.7894736842105	0.0275347844135994	0.161384308712801	1	1	0.953410687097476	0.953410687097476	1
down	EREG; TREH; IGF2; TH; PAX3; LHX1; LHX3; LAMB4;	GO:0009887~animal organ morphogenesis	8	111	7.20720720720721	0.0280948348661609	0.161384308712801	1	1	0.953410687097476	0.953410687097476	1
down	TOX; RGS2; ABL2; DYNLT1; CAMK2B; PTK6; PLPPR5; STYXL1;	GO:0010976~positive regulation of neuron projection development	8	111	7.20720720720721	0.0280948348661609	0.161384308712801	1	1	0.953410687097476	0.953410687097476	1
down	WNT10B; ANXA3; FOSL1; STK3; TAF12; NFAM1; RGCC; MID2;	GO:0051091~positive regulation of DNA-binding transcription factor activity	8	111	7.20720720720721	0.0280948348661609	0.161384308712801	1	1	0.953410687097476	0.953410687097476	1
down	S100A8; GNLY; SLC11A1; PDZD11; RNASE7;	GO:0019730~antimicrobial humoral response	5	52	9.61538461538462	0.028570818436763	0.161384308712801	1	1	0.953410687097476	0.953410687097476	1
down	ZFP36; STK4; STK3; CDS1; NOCT;	GO:0045600~positive regulation of fat cell differentiation	5	52	9.61538461538462	0.028570818436763	0.161384308712801	1	1	0.953410687097476	0.953410687097476	1
down	GABRD; CHRNB4; GABRA3; CHRNA3; GLRB;	GO:0050877~nervous system process	5	52	9.61538461538462	0.028570818436763	0.161384308712801	1	1	0.953410687097476	0.953410687097476	1
down	PSMC4; PSMD8; PSMC6; RBX1; UBA52; PSMB7;	GO:0061418~regulation of transcription from RNA polymerase II promoter in response to hypoxia	6	71	8.45070422535211	0.0289211043554496	0.1631298810577	1	1	0.953410687097476	0.953410687097476	1
down	RBP4; ATF6; FOXC1; BLOC1S3;	GO:0001654~eye development	4	35	11.4285714285714	0.0294151944583567	0.164975431047294	1	1	0.953410687097476	0.953410687097476	1
down	GNLY; RPS19; RPL30; S100A12;	GO:0031640~killing of cells of other organism	4	35	11.4285714285714	0.0294151944583567	0.164975431047294	1	1	0.953410687097476	0.953410687097476	1
down	FOSL1; FOXG1; PTK6; NR2E1;	GO:0045787~positive regulation of cell cycle	4	35	11.4285714285714	0.0294151944583567	0.164975431047294	1	1	0.953410687097476	0.953410687097476	1
down	CNOT1; EXOSC6; NOCT; EXOSC1;	GO:0090503~RNA phosphodiester bond hydrolysis, exonucleolytic	4	35	11.4285714285714	0.0294151944583567	0.164975431047294	1	1	0.953410687097476	0.953410687097476	1
down	HDAC3; EDF1; NCOA2; TNFAIP8L3; ADIPOR1; TRIB3; IRS2;	GO:0019216~regulation of lipid metabolic process	7	92	7.60869565217391	0.0304829195666224	0.17018174616249	1	1	0.953410687097476	0.953410687097476	1
down	SPTA1; LCK; ADD2; TIPARP; RUNX3;	GO:0030097~hemopoiesis	5	53	9.43396226415094	0.0305156444181096	0.17018174616249	1	1	0.953410687097476	0.953410687097476	1
down	LCK; CD3E; PTPN6; CDC42; CD5;	GO:0031295~T cell costimulation	5	53	9.43396226415094	0.0305156444181096	0.17018174616249	1	1	0.953410687097476	0.953410687097476	1
down	RPS3; PRKCE; CRY1; SVBP; SENP2;	GO:0031397~negative regulation of protein ubiquitination	5	53	9.43396226415094	0.0305156444181096	0.17018174616249	1	1	0.953410687097476	0.953410687097476	1
down	HDAC3; XIAP; CRY1; COMMD1; SENP2; UBQLN1;	GO:0031398~positive regulation of protein ubiquitination	6	72	8.33333333333333	0.0305602541798792	0.170190485953862	1	1	0.953410687097476	0.953410687097476	1
up	IDO1; CD300LF; CTLA4; IRF8; IRF4;	GO:0002376~immune system process	5	35	14.2857142857143	0.0308445107865863	0.570197547278194	1	1	0.999999965871282	0.999999965871281	1
down	SOD2; NCF1; NCF4;	GO:0006801~superoxide metabolic process	3	20	15	0.0309712467410479	0.171273160299445	1	1	0.953410687097476	0.953410687097476	1
down	MTX2; TMEM14C; TMEM14B;	GO:0006839~mitochondrial transport	3	20	15	0.0309712467410479	0.171273160299445	1	1	0.953410687097476	0.953410687097476	1
down	EDN2; ADM; SCN3B;	GO:0010460~positive regulation of heart rate	3	20	15	0.0309712467410479	0.171273160299445	1	1	0.953410687097476	0.953410687097476	1
down	INTS12; INTS7; INTS6;	GO:0034472~snRNA 3'-end processing	3	20	15	0.0309712467410479	0.171273160299445	1	1	0.953410687097476	0.953410687097476	1
down	GSTP1; DUSP1; PEBP1;	GO:0043409~negative regulation of MAPK cascade	3	20	15	0.0309712467410479	0.171273160299445	1	1	0.953410687097476	0.953410687097476	1
up	CD19; FCGR2B; TLR8;	GO:0016064~immunoglobulin mediated immune response	3	13	23.0769230769231	0.0315353514000469	0.570197547278194	1	1	0.999999965871282	0.999999965871281	1
up	CCL2; AQP1; CCR2;	GO:0019725~cellular homeostasis	3	13	23.0769230769231	0.0315353514000469	0.570197547278194	1	1	0.999999965871282	0.999999965871281	1
down	ATP6V0E1; ATP6V1G1; ATP6V1F; ATP6V1E2;	GO:0033572~transferrin transport	4	36	11.1111111111111	0.0319268179589705	0.176310947220348	1	1	0.953410687097476	0.953410687097476	1
down	ITGB1BP1; PDCD6; ANXA3; FLT4; FOXC2;	GO:0010595~positive regulation of endothelial cell migration	5	54	9.25925925925926	0.0325416090632749	0.179455400608353	1	1	0.953410687097476	0.953410687097476	1
down	GABARAPL2; CSNK2B; CSNK2A1; CHMP4C; MTERF3; TOMM7; UBQLN1;	GO:0016236~macroautophagy	7	94	7.4468085106383	0.0334765466553394	0.179965567309739	1	1	0.953410687097476	0.953410687097476	1
up	IL10; CNR2; CXCL13; CXCL6;	GO:0030595~leukocyte chemotaxis	4	24	16.6666666666667	0.0336554460767233	0.570197547278194	1	1	0.999999965871282	0.999999965871281	1
up	IL10; IRF8; IRF4; BATF;	GO:0042832~defense response to protozoan	4	24	16.6666666666667	0.0336554460767233	0.570197547278194	1	1	0.999999965871282	0.999999965871281	1
down	PPP1R15A; ATF4; RASGRF1; NRBF2; TRIB3; UBQLN1;	GO:0034976~response to endoplasmic reticulum stress	6	74	8.10810810810811	0.0340177631776787	0.179965567309739	1	1	0.953410687097476	0.953410687097476	1
down	DKK1; HOXC13; LHX2; ALX4;	GO:0001942~hair follicle development	4	37	10.8108108108108	0.0345602760069369	0.179965567309739	1	1	0.953410687097476	0.953410687097476	1
down	WNT10B; PTH1R; OSR2; RUNX3;	GO:0002062~chondrocyte differentiation	4	37	10.8108108108108	0.0345602760069369	0.179965567309739	1	1	0.953410687097476	0.953410687097476	1
down	RPA2; RBX1; UBA52; GTF2H5;	GO:0006296~nucleotide-excision repair, DNA incision, 5'-to lesion	4	37	10.8108108108108	0.0345602760069369	0.179965567309739	1	1	0.953410687097476	0.953410687097476	1
down	GSTZ1; GSTP1; DPEP1; SLC7A11;	GO:0006749~glutathione metabolic process	4	37	10.8108108108108	0.0345602760069369	0.179965567309739	1	1	0.953410687097476	0.953410687097476	1
down	RPA2; RBX1; GTF2H5;	GO:0006293~nucleotide-excision repair, preincision complex stabilization	3	21	14.2857142857143	0.034621560804335	0.179965567309739	1	1	0.953410687097476	0.953410687097476	1
down	CTRB2; MMAB; MTRR;	GO:0009235~cobalamin metabolic process	3	21	14.2857142857143	0.034621560804335	0.179965567309739	1	1	0.953410687097476	0.953410687097476	1
down	FXN; AKIRIN2; OSR2;	GO:0009792~embryo development ending in birth or egg hatching	3	21	14.2857142857143	0.034621560804335	0.179965567309739	1	1	0.953410687097476	0.953410687097476	1
down	METRNL; MTFP1; FIS1;	GO:0014850~response to muscle activity	3	21	14.2857142857143	0.034621560804335	0.179965567309739	1	1	0.953410687097476	0.953410687097476	1
down	FXN; ISCA2; LYRM4;	GO:0016226~iron-sulfur cluster assembly	3	21	14.2857142857143	0.034621560804335	0.179965567309739	1	1	0.953410687097476	0.953410687097476	1
down	CD3E; ZP3; FCER1G;	GO:0032753~positive regulation of interleukin-4 production	3	21	14.2857142857143	0.034621560804335	0.179965567309739	1	1	0.953410687097476	0.953410687097476	1
down	CCL5; HABP4; POLR2G;	GO:0045948~positive regulation of translational initiation	3	21	14.2857142857143	0.034621560804335	0.179965567309739	1	1	0.953410687097476	0.953410687097476	1
down	CHRNA3; KNDC1; NR2E1;	GO:0048814~regulation of dendrite morphogenesis	3	21	14.2857142857143	0.034621560804335	0.179965567309739	1	1	0.953410687097476	0.953410687097476	1
down	LMX1B; EN1; MANF;	GO:0071542~dopaminergic neuron differentiation	3	21	14.2857142857143	0.034621560804335	0.179965567309739	1	1	0.953410687097476	0.953410687097476	1
down	ADRB1; ADRA2C; ADRA1B;	GO:0071880~adenylate cyclase-activating adrenergic receptor signaling pathway	3	21	14.2857142857143	0.034621560804335	0.179965567309739	1	1	0.953410687097476	0.953410687097476	1
down	BCL2L1; FXN; PARL;	GO:0090201~negative regulation of release of cytochrome c from mitochondria	3	21	14.2857142857143	0.034621560804335	0.179965567309739	1	1	0.953410687097476	0.953410687097476	1
down	NR2E1; WNT3; PRDM1; WNT10B; GATA4;	GO:0045165~cell fate commitment	5	55	9.09090909090909	0.0346494500704476	0.179965567309739	1	1	0.953410687097476	0.953410687097476	1
down	MED26; PRKCB; TAF12; PMF1; MED27; TADA1; ARL2BP;	GO:1903508~positive regulation of nucleic acid-templated transcription	7	95	7.36842105263158	0.0350441326392456	0.180657758090713	1	1	0.953410687097476	0.953410687097476	1
down	CNOT1; RPL26; PLK3; RGCC; PLK2;	GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	5	56	8.92857142857143	0.0368398202665382	0.189667512153505	1	1	0.953410687097476	0.953410687097476	1
up	IDO1; FCGR2B; PDCD1LG2;	GO:0032693~negative regulation of interleukin-10 production	3	14	21.4285714285714	0.037061587499288	0.570197547278194	1	1	0.999999965871282	0.999999965871281	1
up	CTAGE4; CTAGE8; CTAGE6;	GO:0035459~vesicle cargo loading	3	14	21.4285714285714	0.037061587499288	0.570197547278194	1	1	0.999999965871282	0.999999965871281	1
up	DRD2; EDNRB; TFAP2B;	GO:0035810~positive regulation of urine volume	3	14	21.4285714285714	0.037061587499288	0.570197547278194	1	1	0.999999965871282	0.999999965871281	1
up	DRD2; EDNRB; AVPR1A;	GO:0035815~positive regulation of renal sodium excretion	3	14	21.4285714285714	0.037061587499288	0.570197547278194	1	1	0.999999965871282	0.999999965871281	1
up	ADRA2A; LILRB2; LILRB1;	GO:0051926~negative regulation of calcium ion transport	3	14	21.4285714285714	0.037061587499288	0.570197547278194	1	1	0.999999965871282	0.999999965871281	1
up	SCNN1G; CYP4A11; TFAP2B;	GO:0055078~sodium ion homeostasis	3	14	21.4285714285714	0.037061587499288	0.570197547278194	1	1	0.999999965871282	0.999999965871281	1
up	RAMP3; CHRNA7; MMP12;	GO:1904645~response to amyloid-beta	3	14	21.4285714285714	0.037061587499288	0.570197547278194	1	1	0.999999965871282	0.999999965871281	1
up	ENPP3; IL2RA; IL10; CNR2; IL13; TNFAIP6; PTGIS; FFAR4; IL22RA2;	GO:0050728~negative regulation of inflammatory response	9	93	9.67741935483871	0.0372852206456884	0.570197547278194	1	1	0.999999965871282	0.999999965871281	1
down	RPA2; RBX1; UBA52; GTF2H5;	GO:0033683~nucleotide-excision repair, DNA incision	4	38	10.5263157894737	0.0373160274746011	0.191123798749446	1	1	0.953410687097476	0.953410687097476	1
down	CCL5; MT3; TYRO3; PLK3;	GO:0043491~protein kinase B signaling	4	38	10.5263157894737	0.0373160274746011	0.191123798749446	1	1	0.953410687097476	0.953410687097476	1
down	ARPC2; CSPG5; S100A10; CDC42;	GO:1900026~positive regulation of substrate adhesion-dependent cell spreading	4	38	10.5263157894737	0.0373160274746011	0.191123798749446	1	1	0.953410687097476	0.953410687097476	1
down	DKK1; ITGB2; MAPT; TP53BP2;	GO:1901216~positive regulation of neuron death	4	38	10.5263157894737	0.0373160274746011	0.191123798749446	1	1	0.953410687097476	0.953410687097476	1
down	CNOT1; UPK2; LMX1B; EDF1; ARIH2; IGF2; PIM1; EN2; HOXA11; HOXC12; TLX1; HOXD13; ARHGDIB; WTAP; BANP; PTP4A1; RADIL; HEMGN; HMX1; DKK2; CFDP1; TYRO3; FLT4; EPHA6;	GO:0007275~multicellular organism development	24	513	4.67836257309941	0.0381910320867768	0.194583857328494	1	1	0.953410687097476	0.953410687097476	1
down	HDAC3; ADRB1; ACADL; UCP2; IL18; ADIPOR2; ADIPOR1;	GO:0120162~positive regulation of cold-induced thermogenesis	7	97	7.21649484536082	0.0383232169662266	0.194583857328494	1	1	0.953410687097476	0.953410687097476	1
down	SOX1; RNMT; GFPT2; CTH; PIGA; B3GNT2; PADI2;	GO:1990830~cellular response to leukemia inhibitory factor	7	97	7.21649484536082	0.0383232169662266	0.194583857328494	1	1	0.953410687097476	0.953410687097476	1
down	CA1; ALDH1L2; MTHFD2;	GO:0006730~one-carbon metabolic process	3	22	13.6363636363636	0.0384837067351751	0.194583857328494	1	1	0.953410687097476	0.953410687097476	1
down	TH; DUSP1; CRY1;	GO:0009416~response to light stimulus	3	22	13.6363636363636	0.0384837067351751	0.194583857328494	1	1	0.953410687097476	0.953410687097476	1
down	CSTB; CAMK2N1; CLN8;	GO:0045861~negative regulation of proteolysis	3	22	13.6363636363636	0.0384837067351751	0.194583857328494	1	1	0.953410687097476	0.953410687097476	1
down	UBA52; TAB3; ITCH;	GO:0070423~nucleotide-binding oligomerization domain containing signaling pathway	3	22	13.6363636363636	0.0384837067351751	0.194583857328494	1	1	0.953410687097476	0.953410687097476	1
down	MIF; EVI2B; RPL23;	GO:0071157~negative regulation of cell cycle arrest	3	22	13.6363636363636	0.0384837067351751	0.194583857328494	1	1	0.953410687097476	0.953410687097476	1
down	TOX; LHX2; NR2E1;	GO:2000179~positive regulation of neural precursor cell proliferation	3	22	13.6363636363636	0.0384837067351751	0.194583857328494	1	1	0.953410687097476	0.953410687097476	1
down	MSX1; ADM; DLX2; FOXC1; AMTN;	GO:0042475~odontogenesis of dentin-containing tooth	5	57	8.7719298245614	0.0391132876797646	0.197011387879986	1	1	0.953410687097476	0.953410687097476	1
down	EREG; CCL5; ALOX12; IL18; RBPMS2;	GO:0048661~positive regulation of smooth muscle cell proliferation	5	57	8.7719298245614	0.0391132876797646	0.197011387879986	1	1	0.953410687097476	0.953410687097476	1
down	TGFA; CCL5; DLX6; EPGN; OSR2;	GO:0050679~positive regulation of epithelial cell proliferation	5	57	8.7719298245614	0.0391132876797646	0.197011387879986	1	1	0.953410687097476	0.953410687097476	1
down	HSBP1; MAPT; RPA2; NUP214; CAMK2B; HIKESHI;	GO:1900034~regulation of cellular response to heat	6	77	7.79220779220779	0.0396609408584609	0.19951572538722	1	1	0.953410687097476	0.953410687097476	1
down	LAMTOR1; CLVS1; HPS4; SNAPIN;	GO:0007040~lysosome organization	4	39	10.2564102564103	0.0401943396696085	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
down	ATF4; PMAIP1; UPP1; CPEB4;	GO:0042149~cellular response to glucose starvation	4	39	10.2564102564103	0.0401943396696085	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
down	SRSF5; THOC7; CHTOP; XPO5; NUP214;	GO:0006405~RNA export from nucleus	5	58	8.62068965517241	0.0414703357857803	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
down	COCH; TH; PAX3; TUB; RPL38; SIX1; HOMER2; TIMM9; TMIE;	GO:0007605~sensory perception of sound	9	143	6.29370629370629	0.0416341911029092	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
down	CETN2; RBX1; UBA52;	GO:0000715~nucleotide-excision repair, DNA damage recognition	3	23	13.0434782608696	0.0425551700238037	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
down	RPA2; RBX1; GTF2H5;	GO:0006295~nucleotide-excision repair, DNA incision, 3'-to lesion	3	23	13.0434782608696	0.0425551700238037	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
down	GOLGA7; COMMD1; EXOC6;	GO:0006893~Golgi to plasma membrane transport	3	23	13.0434782608696	0.0425551700238037	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
down	TH; OPRD1; TCF15;	GO:0042755~eating behavior	3	23	13.0434782608696	0.0425551700238037	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
down	SNAPIN; CDC42; PRMT8;	GO:0043393~regulation of protein binding	3	23	13.0434782608696	0.0425551700238037	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
down	TNFRSF1B; RHEB; IL34;	GO:0048714~positive regulation of oligodendrocyte differentiation	3	23	13.0434782608696	0.0425551700238037	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
down	PRDM1; FOXC1; FOXC2;	GO:0048844~artery morphogenesis	3	23	13.0434782608696	0.0425551700238037	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
down	CDC42; ZFAND1; PLK3;	GO:0090316~positive regulation of intracellular protein transport	3	23	13.0434782608696	0.0425551700238037	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
up	OR2A1; GPR25; P2RY10; FCN1; GPR171; RGS13; CXCL13; GALR3; RAMP3; UTS2; GNA14; ADRA2A; CALCB; DRD2; ADCYAP1; EDNRB; HRH2; FPR3; AVPR2; CNR2; APLNR; AVPR1A; VIPR2; CCR2; PTGFR; GLP1R; GIPR; CXCR3; GPR15; CCR5; TAS2R41; TAS2R50; CXCL6; RGS1; PTGDR; ADGRE1; GRM7; ACKR1; FFAR4; PIK3R6; PREX2; GPR65; OR10AD1; OR52H1; OR52I1; OR10AC1; OR51E1; GPR151; PIK3R5; QRFPR; F2RL3; NPY6R; CCL13; CCL19; P2RY13; ADGRE3; P2RY12; NMUR1; CYSLTR2; TAS2R13; XCL2; CCL14; CCL11; OR13A1; CCL2; CCL18; OR14L1P;	GO:0007186~G protein-coupled receptor signaling pathway	67	1152	5.81597222222222	0.0426457603575713	0.570197547278194	1	1	0.999999965871282	0.999999965871281	1
up	ADCYAP1; GIPR; FFAR4;	GO:0043950~positive regulation of cAMP-mediated signaling	3	15	20	0.0430474993493591	0.570197547278194	1	1	0.999999965871282	0.999999965871281	1
down	WNT10B; PSMC4; PSMD8; PSMC6; UBE2B; XIAP; PIN1; PSMB7; DKK2;	GO:0090263~positive regulation of canonical Wnt signaling pathway	9	144	6.25	0.0431039780519497	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
down	RPA2; CETN2; GTF2H5; COMMD1;	GO:0006289~nucleotide-excision repair	4	40	10	0.0431952934937816	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
down	CPSF4; FIP1L1; ZNF473; SSU72;	GO:0006369~termination of RNA polymerase II transcription	4	40	10	0.0431952934937816	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
down	ACOT4; HSD17B8; MGLL; MECR;	GO:0006633~fatty acid biosynthetic process	4	40	10	0.0431952934937816	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
down	CES1; HSD17B7; IDI1; PMVK;	GO:0006695~cholesterol biosynthetic process	4	40	10	0.0431952934937816	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
down	ATP1A2; SLC7A11; CHRNB4; CHRNA3;	GO:0035094~response to nicotine	4	40	10	0.0431952934937816	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
down	ATG9B; EMC6; UBQLN1; UBQLN2; GABARAPL2;	GO:0000045~autophagosome assembly	5	59	8.47457627118644	0.0439113639193913	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
down	CPSF4; SRSF5; THOC7; FIP1L1; CHTOP;	GO:0031124~mRNA 3'-end processing	5	59	8.47457627118644	0.0439113639193913	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
down	URI1; TH; TNFRSF1B; OPRD1; RACK1;	GO:0071363~cellular response to growth factor stimulus	5	59	8.47457627118644	0.0439113639193913	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
up	DRD2; GPR65; P2RY10; F2RL3; GPR174;	GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	5	39	12.8205128205128	0.0441130442019374	0.570197547278194	1	1	0.999999965871282	0.999999965871281	1
up	CD3G; CD80; CNTNAP1; SLA; CLNK; SKAP1; FCRL2;	GO:0009967~positive regulation of signal transduction	7	67	10.4477611940298	0.0454004633801691	0.570197547278194	1	1	0.999999965871282	0.999999965871281	1
down	GPR137B; S100A8; ANXA7; GABARAPL2; FOXO1; ULK3; VTI1A; NRBF2;	GO:0006914~autophagy	8	123	6.50406504065041	0.0455310879058353	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
down	RPS19; SLC11A1; RPL30; NLRP10; DEFB126; RNASE7;	GO:0050829~defense response to Gram-negative bacterium	6	80	7.5	0.0458642816860564	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
down	MIF; ADAM8; S100A12; EPGN; DIRAS2;	GO:0043406~positive regulation of MAP kinase activity	5	60	8.33333333333333	0.0464366878435213	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
up	FCN1; FGF10; FGF7; ANGPT1;	GO:0034394~protein localization to cell surface	4	27	14.8148148148148	0.0466348695698369	0.570197547278194	1	1	0.999999965871282	0.999999965871281	1
down	VASN; ADIPOR1; SDHAF2;	GO:0010719~negative regulation of epithelial to mesenchymal transition	3	24	12.5	0.0468329858661233	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
down	MEFV; SLC11A1; IFITM2;	GO:0034341~response to interferon-gamma	3	24	12.5	0.0468329858661233	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
down	CLTA; AP2S1; NPC2;	GO:0034383~low-density lipoprotein particle clearance	3	24	12.5	0.0468329858661233	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
down	IGF2; SORL1; ADIPOR1;	GO:0046628~positive regulation of insulin receptor signaling pathway	3	24	12.5	0.0468329858661233	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
down	AP2S1; CLTA; DNAJC6;	GO:0072583~clathrin-dependent endocytosis	3	24	12.5	0.0468329858661233	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
up	ADCYAP1; AVPR2; VIPR2; GLP1R; GIPR;	GO:0007190~activation of adenylate cyclase activity	5	40	12.5	0.0478878415011266	0.570197547278194	1	1	0.999999965871282	0.999999965871281	1
down	TIMP2; ADRA2C; FOXG1; GDF6; ARHGEF2; SH3GL3;	GO:0045666~positive regulation of neuron differentiation	6	81	7.40740740740741	0.0480583841921334	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
up	CXCL13; CCR2; XCL2;	GO:0010820~positive regulation of T cell chemotaxis	3	16	18.75	0.0494836431905001	0.570197547278194	1	1	0.999999965871282	0.999999965871281	1
down	MB; TUB; FOXC2; TIMP2;	GO:0009725~response to hormone	4	42	9.52380952380952	0.049564550413415	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
down	ISL1; FOXC1; GLIPR2; RGCC;	GO:0010718~positive regulation of epithelial to mesenchymal transition	4	42	9.52380952380952	0.049564550413415	0.201217529474537	1	1	0.953410687097476	0.953410687097476	1
